US20020012910A1 - Automated hybridization/imaging device for fluorescent multiplex dna sequencing - Google Patents
Automated hybridization/imaging device for fluorescent multiplex dna sequencing Download PDFInfo
- Publication number
- US20020012910A1 US20020012910A1 US08/563,462 US56346295A US2002012910A1 US 20020012910 A1 US20020012910 A1 US 20020012910A1 US 56346295 A US56346295 A US 56346295A US 2002012910 A1 US2002012910 A1 US 2002012910A1
- Authority
- US
- United States
- Prior art keywords
- hybridization
- membrane
- chamber device
- probe
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000009396 hybridization Methods 0.000 title claims abstract description 125
- 238000003384 imaging method Methods 0.000 title claims abstract description 68
- 238000001712 DNA sequencing Methods 0.000 title description 8
- 239000012528 membrane Substances 0.000 claims abstract description 176
- 239000012530 fluid Substances 0.000 claims abstract description 112
- 238000000034 method Methods 0.000 claims abstract description 87
- 238000012163 sequencing technique Methods 0.000 claims abstract description 70
- 239000000047 product Substances 0.000 claims abstract description 67
- 239000000523 sample Substances 0.000 claims abstract description 62
- 102000004190 Enzymes Human genes 0.000 claims abstract description 55
- 108090000790 Enzymes Proteins 0.000 claims abstract description 55
- 230000027455 binding Effects 0.000 claims abstract description 39
- 239000002773 nucleotide Substances 0.000 claims abstract description 32
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 31
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 26
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 claims abstract description 18
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims abstract description 8
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims abstract description 8
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 8
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000002105 Southern blotting Methods 0.000 claims abstract description 4
- 238000001262 western blot Methods 0.000 claims abstract description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 29
- 102000039446 nucleic acids Human genes 0.000 claims description 29
- 150000007523 nucleic acids Chemical class 0.000 claims description 29
- 238000001514 detection method Methods 0.000 claims description 22
- 238000001962 electrophoresis Methods 0.000 claims description 22
- BTKMJKKKZATLBU-UHFFFAOYSA-N [2-(1,3-benzothiazol-2-yl)-1,3-benzothiazol-6-yl] dihydrogen phosphate Chemical group C1=CC=C2SC(C3=NC4=CC=C(C=C4S3)OP(O)(=O)O)=NC2=C1 BTKMJKKKZATLBU-UHFFFAOYSA-N 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 20
- 239000000758 substrate Substances 0.000 claims description 20
- 238000012546 transfer Methods 0.000 claims description 17
- 108091034117 Oligonucleotide Proteins 0.000 claims description 13
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 13
- 239000002751 oligonucleotide probe Substances 0.000 claims description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- 239000004677 Nylon Substances 0.000 claims description 10
- 229920002521 macromolecule Polymers 0.000 claims description 10
- 229920001778 nylon Polymers 0.000 claims description 10
- 230000010354 integration Effects 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 230000002452 interceptive effect Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 5
- 238000013507 mapping Methods 0.000 claims description 4
- 108700028369 Alleles Proteins 0.000 claims description 3
- 108091092878 Microsatellite Proteins 0.000 claims description 3
- 108010090804 Streptavidin Proteins 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 238000003205 genotyping method Methods 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000002313 adhesive film Substances 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims 3
- 108090001008 Avidin Proteins 0.000 claims 2
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 claims 2
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 claims 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 claims 2
- 238000001502 gel electrophoresis Methods 0.000 claims 1
- 238000000636 Northern blotting Methods 0.000 abstract description 3
- 108020004414 DNA Proteins 0.000 description 43
- 239000000243 solution Substances 0.000 description 20
- 239000000499 gel Substances 0.000 description 19
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 15
- 239000002953 phosphate buffered saline Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000012634 fragment Substances 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 8
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000000712 assembly Effects 0.000 description 6
- 238000000429 assembly Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000013508 migration Methods 0.000 description 5
- -1 polypropylene Polymers 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- HWMVXEKEEAIYGB-UHFFFAOYSA-K Isocitric acid, DL- Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C(O)C(C([O-])=O)CC([O-])=O HWMVXEKEEAIYGB-UHFFFAOYSA-K 0.000 description 1
- 229920004142 LEXAN™ Polymers 0.000 description 1
- 239000004418 Lexan Substances 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 208000003019 Neurofibromatosis 1 Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 239000008051 TBE buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Definitions
- FIG. 3 shows an enlarged cross sectional view of an illustrative check valve contained in the automated imaging hybridization chamber shown in FIG. 2.
- the blot was moved perpendicularly to the camera on a translation stage consisting of a Model 506241S rail table, MD series drive, and a MC. 3000 controller unit(DAEDAL Inc., Harrison City, PA). Two sets of lanes were acquired at 150 dots per inch in 8 minutes of scan time. Image data were downloaded from the camera controller frame buffer to a 286 PC-AT microcomputer, transferred to a Macintosh Tromping, and then to a DEC. 5000 workstation for base-calling and sequence analysis, described in detail below.
- the integrated imaging system also advantageously contains an imaging assembly 106 for obtaining an image of the pattern of hybridization to membrane-bound nucleic acid while the membrane 32 is within the chamber compartment 36 .
- the sidewall 22 of outer cylinder 20 contains a window 24 of optically transparent material through which the membrane 32 mounted on the exterior surface of the sidewall 14 of inner 12 may be visualized.
- a suitable material for the window 24 is LEXAN, although other materials may function equally well.
- the window 24 may become fogged by condensation within the chamber compartment 36 , however the heating element 92 defogs the window 24 .
- an interior wiper (not shown) can be used to defog the window 24 .
- the automated reader yielded reasonably accurate sequence as far as the membrane was imaged, 653 nucleotides from the primer. There were 8 total errors (7 deletions and one substitution) in the 581 nucleotides deciphered, for an error rate of 1.4%. The first error occurred 381 nucleotides from the primer. Four of the eight errors occurred within the last 39 nucleotides and two of the remaining errors were due to compression and false stop artifacts.
- Dynabeads have an iron component that permits magnetic concentration of the beads and the bound DNA-Sequencing reaction products were loaded on a 4% polyacrylamide gel and subjected to electrophoresis as described in Example 1.
- Fractionated DNA fragments were directly transferred to a nylon membrane using the custom direct transfer apparatus described above.
- the membrane was removed from the apparatus, rehydrated in 40 mM sodium phosphate buffer, pH 7.6, and irradiated with a total of 225 mJ/cm 2 of UV light to cross link the DNA fragments to the nylon membrane. Unbound DNA was removed by washing the membrane in PBS (40 mM sodium phosphate, pH 7.6, 150 mM NaC. I), 5% SDS, and then the membrane was placed in the automated imaging hybridization chamber.
- the controller was programmed for automatic operation and the steps described below proceeded automatically in a cycle time of 4.5 hours.
- conjugate solution was drained and unbound conjugate was removed by 1 wash with PBS, 5% SDS; 1 wash with PBS, 1 SDS; 3 washes with PBS; and 3 washes with 0.1 M diethanolamine, pH 10.0, 1 mM MgCl 2 , 0.01 % sodium azide.
- the limits of detection for a single biotin are 5 and 1 attomoles (10 ⁇ 10 moles) for direct detection and 14 and 2 attomoles for a hybridized probe, respectively.
- Quantities of sequencing template in the 0.5 pmol range typically yield a few hundred attomoles of dideoxy-terminated chain per band.
- the technique described herein has the sensitivity required for low-level multiplexing ( ⁇ 10 reprobings), and the use of probes with multiple biotin molecules or the use of various amplification schemes should increase the signal further and allow for deep levels of multiplexing.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Clinical Laboratory Science (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Electrochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A method is disclosed for automated multiplex sequencing of DNA with an integrated automated imaging hybridization chamber system. This system comprises an hybridization chamber device for mounting a membrane containing size-fractionated multiplex sequencing reaction products, apparatus for fluid delivery to the chamber device, imaging apparatus for light delivery to the membrane and image recording of fluorescence emanating from the membrane while in the chamber device, and programmable controller apparatus for controlling operation of the system. The multiplex reaction products are hybridized with a probe, then an enzyme (such as alkaline phosphatase) is bound to a binding moiety on the probe, and a fluorogenic substrate (such as a benzothiazole derivative) is introduced into the chamber device by the fluid delivery apparatus. The enzyme converts the fluorogenic substrate into a fluorescent product which, when illuminated in the chamber device with a beam of light from the imaging apparatus, excites fluorescence of the fluorescent product to produce a pattern of hybridization. The pattern of hybridization is imaged by a CCD camera component of the imaging apparatus to obtain a series of digital signals. These signals are converted by the controller apparatus into a string of nucleotides corresponding to the nucleotide sequence an automated sequence reader. The method and apparatus are also applicable to other membrane-based applications such as colony and plaque hybridization and Southern, Northern, and Western blots.
Description
- [0001] This invention was made with government support under Grant No. DE-FG02-88ER60700 awarded by the U.S. Department of Energy and Grant Nos. RO1-HGO0517-02 and P30-HGO00199-03 awarded by the National Center for Human Genome Research of the National Institutes of Health. The government has certain rights in the invention.
- This invention relates generally to the field of nucleic acid hybridization on membranes. More particularly, this invention relates to a method for automated multiplex sequencing of DNA.
- Large scale nucleotide sequencing initiatives, such as a project to sequence the human genome, have created a need for increased efficiency and productivity. J. Watson, 248 Science 44 (1990). Automation of the various steps involved in sequencing is one area in which gains in efficiency and productivity are being made.
- Multiplex sequencing, one scheme for reducing the number of sequencing reactions and electrophoresis steps, involves the processing of a mixture of sequencing templates followed by sequential hybridization with selected probes. G. Church & S. Kieffer-Higgins, 240 Science 185 (1988); U.S. Pat. No. 4,942,124. In this method, many sequencing templates, each carrying a short known sequence or tag, are processed together. A single DNA preparation yields a mixture of templates. Sequencing reactions are performed on the mixture in the absence of any label, and the mixed reaction products are fractionated by electrophoresis, transferred to a membrane, and probed sequentially by hybridization with labeled oligonucleotides specific for each tag. Each hybridization step reveals the nucleotide sequence of one component of the template mixture. Between hybridizations the labeled probe is removed to permit the next hybridization without interference from the previous probe. The advantages of multiplex sequencing come from the parallel processing of template preparations and sequencing reactions, and the simultaneous electrophoresis of mixtures of templates. Multiplex sequencing can reduce the time, effort, and resources needed for these steps by about a factor of the number of is different sequencing templates in the mixture.
- The savings made in sequencing reactions and electrophoresis by multiplex sequencing are offset to some extent, however, by new steps that are unnecessary in conventional sequencing protocols. Hybridization of the membrane is an added step that is repeated with each specific probe. Fortunately, however, the hybridization process is automatable. P. Richterich et al., 7 Bio/Techniques 52 (1989). A remaining problem is the acquisition of sequence data in electronic form. Automated sequencing machines are available that detect fluorescently labeled sequencing products as they migrate through a gel. The data acquired in this way are then interpreted by an algorithm that yields a called sequence. Most large-scale sequencing efforts have turned toward such machines as the only way of obtaining sufficient efficiency.
- Conventionally, hybridization probes have been labeled with radioisotopes. Although radioactive probes can detect minute g quantities of DNA, they are hazardous and unstable, and high-resolution direct imaging of radioactive signals is not straight-forward. Non-radioactive methods of DNA detection have been developed in recent years. The most sensitive methods involve enzymatic conversion of substrates to colored, J. Leary et al., 80 Proc. Nat'l Acad. Sci. USA 4045 (1983), or chemiluminescent products, J. Voyta et al., 34 J. Clin. Chem. 1157 (1988); A. Schaap et al., 28 Tetrahedron Lett. 1159 (1987); I. Bronstein et al. 180 Anal. Biochem. 95 (1989). In this approach, an enzyme is linked to a probe, and an enzyme substrate that yields a colored or chemiluminescent product is applied to the membrane. After the enzyme acts on the substrate, the result is a pattern of color or light corresponding to the pattern of the target DNA on the membrane. Although calorimetric detection of sequence ladders has been achieved, P. Richterich et al, 7 Bio/Techniques 52 (1989), the inability to remove the colored product from the membrane precludes its use for sequential probing.
- As currently practiced, automated DNA sequencing makes use of fluorescent labels for DNA detection. L. Smith et al., 321 Nature 674 (1986); W. Ansorge et al., 15 Nucleic Acids Res. 4593 (1987); J. Prober et al., 238 Science 336 (1987). In these methods fluorescence detection occurs while the DNA is in the gel. Under such conditions, a single fluorescent moiety per DNA molecule is sufficient for detection. Attempts at fluorescent detection in multiplex sequencing revealed a grossly inadequate limit of detection for DNA sequencing purposes. A. Karger et al., 206 Proc. SPIE 78 (1990). Background fluorescence from most membranes adds large quantities of noise, T. Chu et al., 13 Electrophoresis 105 (1992); U.S. Pat. No. 5,112,736, so that a much more intense signal is required to achieve an adequate signal-to-noise ratio than is required in a gel. Low fluorescence membranes, such as amine derivatized polypropylene (e, g., U.S. Pat. No. 5,112,736), are known, however such low flourescence membranes are restricted by a limit of detection about 100-fold too high for multiplex sequencing and the membranes are more fragile than nylon membranes.
- Chemiluminescent hybridization signals are typically imaged by exposure to X-ray film although other methods are known, such as with a CCD (charge-coupled device) camera. U.S. Pat. No. 5,162,654. However the light output from chemiluminescence is quite low. Although enzymatic turnover results in many chemiluminescent molecules per target DNA molecule, at most one photon is emitted for each product molecule produced and in practice there is only about 1 photon emitted per 10 4 molecules. Due to the low level of light emitted, a sensitive, low-noise detector, such as a cryogenically cooled CCD, is required for imaging, and a long exposure time is needed. A fully automated system based on chemiluminescence could be constructed, but it would be expensive and slow.
- In the most straightforward operational mode, a CCD image is acquired as a snapshot, analogous to the operation of a photographic camera. The major advantages of digital imaging, in particular fast visualization, high sensitivity, quantitative imaging, and computer readable format, have been well documented. E. Ribeiro et al., 194 Anal. Biochem. 174 (1991); P. Jackson et al., 9 Electrophoresis 330 (1988); P. Jackson, 270 Biochem. J. 705 (1990); K. Chan et al., 63 Anal. Chem. 746 (1991); M. Lanan et al., 31 Biopolymers 1095 (1991); M. Lanan et al., 64 Anal. Chem. 1967 (1992); A. Karger et al., 1206 Proc. SPIE 78 (1990); K. Misiura et al. 18 Nucleic Acids Res. 4345 (1990); D. Pollard-Knight et al., 185 Anal.Biochem. 84 (1990); Z. Boniszewski et al., 11 Eleccrophoresis 432 (1990). When compared to other methods of visualization, however, such as autoradiography using isotope labels and X-ray film, the most obvious limitation of CCD imaging lies in the dimensions of the sensor arrays most commonly used in analytical applications. Their limited size rules out the recording of high-resolution electropherograms on a single frame. The large number of bands that can be resolved by high-resolution electrophoretic methods far exceeds the number of bands that can be adequately sampled on arrays having 512 to 768 CCD elements along their long axis, such as those referenced above.
- One solution to obtaining a CCD image with adequate sampling over the entire surface of sequencing electropherograms is by manually merging partially overlapping individual frames on a computer screen using an image analysis tool. P. Jackson, 270 Biochem. J. 705 (1990). However, this procedure is time consuming and labor intensive, and the quality of the resulting composite image is compromised by discontinuities.
- Another solution would be to use larger CCD arrays. CCD arrays consisting of 2048 elements square are commercially available, although at prices that are often prohibitive for analytical applications. Considering that several thousand data points need to be collected when several hundred bands are being separated, even a state-of-the-art, 4-megapixel CCD area array will fall short of the most demanding requirements of high-resolution separations. DNA sequencing, for example, requires sampling capability for well above 500 bands on a single lane, translating into much more than 2048 data points.
- Continuous data acquisition using an area CCD can be achieved by operating the CCD camera in Time Delay and Integration (TDI) mode. Line scan CCD cameras are also available, but TDI mode provides greater sensitivity than line scan. TDI operation adds the capability of continuous data acquisition independent of the array length. this has been shown for two high-speed, fluorescence DNA sequencing formats: capillary electrophoresis, A. Karger, et al., 18 Nucleic AcidsRes. 4955 (1991), and ultrathin slab gels, A. Kostichka et al., 10 Bio/Technology 78 (1992). TDI mode has also been used to monitor migrating fluorescent bands in capillary electrophoresis along the length of the column with a CCD camera. J. Sweedler et al., 63 Anal. Chem. 496 (1991). A TDI system for fluorescence detection on membranes is needed for automation of multiplex sequencing.
- The task of converting relative band positions into nucleotide sequence is conceptually simple, however, the 1-3% error rate of human readers indicates that reading is more complex in practice. Band amplitudes and positions vary due to enzyme behavior and other biochemical factors, and instrumentation and handling factors, such as uneven temperature distribution. Band positions as a function of fragment size typically follow either quasi-logarithmic or constant spacing rules, depending on the instrumentation, but spatial jitter and position anomalies can be large enough to superimpose adjacent bands. Interlane band amplitudes vary, and intralane band amplitudes change both locally and along the length of the lane. Across a given electrophoretic gel, bands change width and my be tilted or take on complex shapes. Automated sequence readers must be able to deal with all this variation.
- It is an object of the present invention to provide a system and method for automated multiplex sequencing of DNA.
- It is also an object of the invention to provide an apparatus for automatic hybridization and washing of sequencing membranes, detection and imaging of fluorescent signals, and producing a called sequence with existing software from sequence data on the sequencing membranes.
- An additional object is to provide an apparatus capable of handling other membrane-based detection methods such as colony and plaque hybridizations; Southern, Northern, and Western blot procedures; multiplex genotyping of simple sequence repeats; sequencing and mapping by hybridization; and dot, slot, and allele-specific oligonucleotide blot techniques.
- It is another object of the invention to provide a system and method for detecting DNA on sequencing membranes that is compatible with automated multiplex sequencing.
- It is a further object of the invention to provide a system and method for imaging fluorescent signals on sequencing membranes that is compatible with automated multiplex sequencing and which is also applicable to other membrane-based detection methods.
- Yet a different object is to provide a method for enzyme-linked fluorescent detection of membrane-bound nucleic acid
- These and other objects may be accomplished by a method for sequencing a nucleic acid specimen by automated multiplex sequencing comprising the steps of (a) preparing multiplex sequencing reaction products, (b) separating the sequencing products according to their size, (c) attaching the separated sequencing products to a membrane, (d) placing the membrane in a chamber device of an integrated automated imaging hybridization chamber system comprising an hybridization chamber device, means for fluid delivery to the chamber device, imaging means for light delivery to the membrane and image recording of fluorescence emanating from the membrane while in the chamber device, and controller means for controlling the operation of the system, (e) introducing a first oligonucleotide probe containing an enzyme binding moiety, the probe capable of specifically hybridizing with a tag sequence on the membrane-bound sequencing products, into the chamber device by the fluid delivery means and thereby hybridizing the probe to the fractionated products, (f) introducing an enzyme into the chamber device by the fluid delivery means and binding enzyme to the binding moiety on the first oligonucleotide probe, (g) introducing a fluorogenic substrate into the chamber device by the fluid delivery means and contacting the enzyme with the substrate so that the substrate is converted into a fluorescent product, (h) illuminating the fluorescent product in the chamber device with a beam of light from the imaging means to excite fluorescence of the fluorescent product and produce a pattern of hybridization that reflects the nucleotide sequence of the nucleic acid specimen, (i) imaging the hybridization pattern by the imaging means and storing the pattern of hybridization as digital signals, and (j) converting the digital signals by the controller means into a linear string of nucleotides corresponding to the nucleotide sequence of the nucleic acid specimen.
- Another aspect of the invention is adding the additional steps of (k) removing the fluorescent product from the membrane by introducing an appropriate wash solution into the chamber compartment by the fluid delivery means, (1) introducing a second oligonucleotide probe, containing a binding moiety to which an enzyme may be bound and which is able to hybridize specifically with a tag sequence different than the tag sequence of step (e), into the chamber device by the fluid delivery means and hybridizing the second probe to the fractionated products, introducing an enzyme into said chamber device by the fluid delivery means and binding the enzyme to the binding moiety on the second oligonucleotide probe, and repeating steps (g) through (j)
- Another aspect of the invention is providing a fluorogenic substrate that is converted into a fluorescent product by an enzyme, wherein enzyme turnover produces many copies of the fluorescent product, the fluorescent product produces a clear pattern of hybridization with the support-bound nucleic acid, and the fluorescent product is easily removed for subsequent rounds of hybridization. Illustrative of suitable fluorogenic substrates is the benzothiazole derivative, 2′-(2-benzothiazolyl)-6′-hydroxybenzothiazole phosphate (BBTP)-Alkaline phosphatase catalyzes the conversion of BBTP into the fluorescent product BBT. BBT does not diffuse on nylon membranes thus providing a sharp fluorescent image of membrane-bound DNA when illuminated with a wavelength of light that excites fluorescence. BBT is easily removed from the membrane by washing in detergent so that subsequent hybridizations can be performed on the same membrane.
- Another aspect of the invention is an automated imaging hybridization chamber for automatic hybridization and imaging of multiplex sequencing membranes. The automated imaging m hybridization chamber comprises a pair of concentric nested horizontal cylinders, i.e., a sealed inner cylinder that is rotatable about an axis and a sealable stationary outer cylinder having a light transparent window and entry means through which the inner cylinder may be accessed.The outer surface of the inner cylinder, containing means for attaching the sequencing membrane thereto, is spaced apart from the inner surface of the outer cylinder thereby forming an enclosed chamber compartment, the lower portion of which may be employed for receiving fluids (referred to as a “fluid puddle”) used in the hybridization process. The portion of the chamber compartment above the fluid is an air space through which the membrane may be visualized and subjected to light through the transparent window in the outer cylinder. The inner cylinder is rotatable on an axle and is coupled to a stepper motor through gears and a toothed belt for causing the inner cylinder to rotate. The underside of the outer cylinder contains a plurality of valved ports extending through the cylinder wall through which fluids may be injected and removed from the chamber without cross contamination of the fluids. Each port is either coupled to a fluid delivery module for storing and delivering the fluids to the chamber compartment or to drain means for removing fluid from the chamber compartment. One type of fluid delivery module includes a large capacity reservoir and a metering pump. Optionally, a batch heater is included for heating the fluids before they are inserted into the chamber. A second type of fluid delivery module includes a probe reservoir, a large capacity reservoir, and a dual headed peristaltic pump for mixing probes with other solutions and delivering the fluid mixture to the chamber. Probe reservoirs can also be of the non-mixing type. Optionally, a refrigeration unit may be included to chill probe or other solutions.
- Another aspect of the invention includes an imaging apparatus for imaging the pattern of hybridization on the membrane while the membrane is within the chamber. The outer cylinder advantageously includes a window of optically transparent material through which visible light may pass. A light source appropriately positioned outside the outer cylinder relative to the transparent window illuminates the membrane at a wavelength of light for exciting Fluorescence of the fluorescent product on the membrane. A lens can be used to widen the distribution of the beam of light. A filter removes unwanted wavelengths of light. A CCD camera also appropriately positioned outside the outer cylinder relative to the transparent window operating in Time Delay and Integration mode records an image of the pattern of hybridization produced by the fluorescence. A filter removes interfering wavelengths of light from background sources. To generate an image, the membrane, which is mounted on the inner chamber, is moved relative to the CCD camera. This movement is caused by rotation of the inner chamber by the stepper motor and is synchronized with CCD pixel shifts in the camera. The image is stored electronically.
- The above provides an overall summary of a preferred embodiment to a complete and integrated system and method for multiplex DNA sequencing. However, portions of the integrated system and/or method taken separately or combined may be utilized in other embodiments. For example, hybridization means other than the automated chamber may be utilized in a multiplexing operation. Also, membrane bound nucleic acids may be detected by enzyme-linked fluorescence without using the specific hybridization chamber or the specific imaging means disclosed, Further, the disclosed hybridization chamber can be used without the disclosed imaging means and/or fluorescence system.
- FIG. 1A shows a portion of a sequencing membrane corresponding to nucleotides 290-373 from the sequencing primer at 65 minutes, 110 minutes, and 20 hours after addition of the fluorogenic substrate MUFP.
- FIG. 1B shows a portion of a sequencing membrane corresponding to nucleotides 290-373 from the sequencing primer at 40 minutes, 110 minutes, and 23 hours after addition of the fluorogenic substrate 5MFP.
- FIG. 1C shows a portion of a sequencing membrane corresponding to nucleotides 290-373 from the sequencing primer at 40 minutes, 110 minutes, and 20 hours after addition of the fluorogenic substrate BBTP.
- FIG. 2 is a schematic perspective view of the automated imaging hybridization chamber system according to the present invention.
- FIG. 3 shows an enlarged cross sectional view of an illustrative check valve contained in the automated imaging hybridization chamber shown in FIG. 2.
- FIG. 4 shows an end sectional view of a portion of the automated imaging hybridization chamber shown in FIG. 2 taken along lines 4-4 of FIG. 2.
- FIG. 5 shows a plot of unprocessed one-dimensional traces of a portion of a sequencing membrane read according to the present invention. The line patterns represent the four deoxynucleotides: T (solid), C (dashed), G (dotted), and A (dash-dot).
- FIG. 6 shows the detection limit of a membrane-bound 75-mer oligonucleotide in a single direct transfer electrophoresis sequence band wherein the 75-mer oligonucleotide was probed with a complementary 25-mer oligonucleotide labeled with a single 5′ biotin and detected with streptavidin-alkaline phosphatase and BBTP.
- FIG. 7 shows the detection limit of a membrane-bound 75-mer oligonucleotide in a single direct transfer electrophoresis sequence band wherein the 75-mer oligonucleotide was labeled directly with a single 5′ biotin and detected with streptavidin-alkaline phosphatase and BBTP.
- Before the present method of automated multiplex nucleotide sequencing is disclosed and described, it is to be understood that this invention is not limited to the particular process steps and materials disclosed herein as such process steps and materials may vary somewhat. It is also to be understood that the terminology used herein is used for the purpose of describing particular embodiments only and is not intended to be limiting since the scope of the present invention will be limited only by the appended claims and their equivalents.
- As used herein, “membrane” includes thin films composed of nylon, nitrocellulose, polypropylene, and the like, as well as their functional equivalents now known in the art or later developed. Also, other solid supports to which a nucleic acid may be bound, hybridized and detected by enzyme-linked fluorescence is considered a functional membrane equivalent even if not in the form of a thin film.
- As used herein, “macromolecule” means a nucleic acid or protein or their functional equivalents. For example, nucleic acid is intended to include naturally occurring and synthetic oligonucleotides and polynucleotides regardless of whether they contain ribose, deoxyribose, or dideoxyribose sugars or a combination thereof, and regardless of whether they are single stranded, double stranded, or a combination thereof. Protein is intended to include oligopeptides and polypeptides, whether naturally occurring or synthetic.
- Enzyme-Linked Fluorescent Detection of DNA
- One way of increasing fluorescent light output is to make use of enzymatic turnover to yield many fluorescent molecules per target DNA molecule. Fluorogenic substrates, compounds exhibiting low fluorescence which yield highly fluorescent products when acted upon by an enzyme, are available for several enzymes. Each molecule of enzyme can catalyze the production of many fluorescent molecules. The following fluorogenic substrates for calf intestinal alkaline phosphatase were tested as agents for visualization of probed DNA sequence ladders on nylon membranes: β-methylumbelliferyl phosphate (MUFP), 5-methyl fluorescein phosphate ( 5MFP), and 2′-(2-benzothiazolyl)-6′-hydroxybenzothiazole phosphate (BBTP). MUFP is commonly used in fluorescent assays for alkaline phosphatase, whereas 5MFP is a weakly fluorescent compound that, when hydrolyzed, yields the methyl ether of the common fluorophore, fluorescein. BBTP, also known as “NATTOPHOS,” R. Cano et al., 12 BiolTechniques 264 (1992), is hydrolyzed by alkaline phosphatase to the highly fluorescent 2′-(2-benzothiazolyl)-6′-hydroxybenzothiazole (BBT). R. Klem & W. Marvin, Preparation and Use of Fluorescent Benzothidzole Derivatives, PCT WO 90/00618 (Jan. 25, 1990). While BBT is the preferred substrate thus far considered, the invention is not limited to any particular chemical structure for a fluorogenic substrate. Any substrate which does not diffuse on the membrane of choice thereby providing a sharp fluorescent image of membrane-bound DNA when illuminated with a wavelength of light that excites fluorescence is suitable. Preferably the substrate will also be is easily removed from the membrane by washing in detergent so that subsequent hybridizations can be performed on the same membrane.
- A sequencing reaction was prepared using the dideoxynucleotide chain termination method of F. Sanger et al., 74 Proc. Nat′l Acad. Sci USA 5464 (1977), with 1 pmol of M13mp19 template DNA and T7 DNA polymerase. Single-stranded template DNA was prepared from M13mp19 phage grown and purified from E. coli 71-18 using polyethylene glycol/NaCl precipitation followed 1y phenol/chloroform extraction and ethanol precipitation. J. Messing et al., 9 Nucleic Acids Res. 309 (1981). For sequencing, 2 pmol of “universal” sequencing primer and 1 pmol of template DNA were annealed in a 10 μl volume containing 4 mM MnCl2, 80 mM Tris HCl, pH 7.6, 30 mM sodium isocitrate, 10 mM dithiothreitol, and 0.1 μM of each of the four deoxynucleoside triphosphates. Annealing was at 65° C. for two minutes, then at 37°C. for 15 minutes, before addition of 2 units of T7 DNA polymerase (Sequenase 2.0, U.S. Biochemicals). After 1 minute at room temperature, 2.5 μl of this mixture was placed into each of four microtiter wells containing 2.5 μl of the appropriate deoxy-(dNTP) and dideoxy-(ddNTP) nucleotides. μl d/ddNTP mixtures contained 300 μdNTP and 1 μM of the appropriate ddNTP. The reaction was incubated at,37° C. for 8 minutes and terminated by the addition of 6 μl of stop solution containing 98% formamide, 0.1% xylene cyanol, and 0.1% bromphenol blue, and heating on a boiling water bath for 3 minutes.
- Reaction products were loaded in three sets of four lanes each (corresponding to the four deoxynucleotides A, C. , G, and T), and were fractionated and then transferred to a nylon membrane. A 4% acrylamide slab gel (Long Ranger Gel Solution, AT BioC. hem Inc., Malvern, PA) containing 1×TBE buffer (89 mM Tris base, 89 mM boric acid, 2 mM EDTA, pH 8.3) was poured between 80 cm×35 cm glass plates using a 0.2 mm to 0.1 mm reverse wedge spacer. Gels were prerun at 50 V/cm, then 0.75 μl of sequence reaction was loaded per lane. DNA fragments were fractionated at 50 V/cm with passive thermostating provided by aluminum plates clamped co both glass surfaces. The electrophoresis system was a direct transfer apparatus, F. Pohl & S. Beck, 155 Meth. Enzymol. 250 (R. Wu ed., 1987) and hereby incorporated by reference, containing a custom stepper motor and controls, that pulls the membrane at a constant rate perpendicular to the bottom edge of the glass plates, thus, transferring the DNA fragments to the membrane. Conventional methods of transferring DNA from gels to membranes, such as electroblotting as described in U.S. Pat. No. 5,112,736, would also be adequate. After electrophoresis and transfer, the membrane was removed from the apparatus, rehydrated in 40 mM sodium phosphate buffer, pH 7.6, and irradiated with a total of 225 mJ/cm2 of UV light to cross link the DNA fragments to the nylon membrane. Unbound DNA was removed by washing the membrane in PBS (40 mM sodium phosphate, pH 7.6, 150 mm NaCl), 5% SDS, and then the membranes were stored in the same buffer
- The membrane from Example 1 was placed in an automated imaging hybridization chamber, to be described momentarily, where it was probed with a biotinylated oligonucleotide complementary to positions 80 to 110 of the ladder, and then treated with a streptavidin-alkaline phosphatase conjugate. Complete cycle time was 4.5 hours. The rotation of the inner cylinder within the hybridization chamber device was set to sweep a bead of fluid across the convex surface of the membrane, by movement of the membrane through the fluid, at approximately 20 second intervals. Hybridization volumes were 50 ml total, and wash volumes were 100 ml each. Unbound probe was removed by 8 washes with phosphate buffered saline (PBS) containing 5% SDS. Then a 1/5000 dilution of streptavidin-alkaline phosphatase (Boehringer Mannheim, 1000 U/ml) was applied in a total volume of 40 ml of PBS, 5% SDS. The enzyme conjugate was allowed to bind for 45 minutes. Then, unbound conjugate was removed by 1 wash with PBS, 5% SDS; 1 wash with PBS, 1% SDS; 3 washes with PBS; and 3 washes with 0.1 M diethanolamine, pH 10.0, 1 mM MgCl 2, 0.01% sodium azide.
- The membrane from Example 2 was cut so that each of the three substrates could be applied to a sequencing ladder. The enzymatic reaction was started by addition of 1 ml of a fluorogenic alkaline phosphatase substrate for every 300 cm 2 of membrane. The stock solutions were: MUFP-50 μg/ml in 0.1 M diethanolamine,
pH 10; 5MFP-50 μg/ml in 0.1 M diethanolamine,pH 10; and BBTP-600 μg/ml in 2.4 mM diethanolamine,pH 10. The substrate solution was applied as an even coat on the membrane. - In this example, the membranes were imaged outside the chamber, thus membranes were then placed on glass plates and wrapped with transparent plastic film. Fluorescence emission was excited by a 458 nm line of an argon ion laser (Lexel model 96) for 5MFP and BBTP or a long wave UV mercury lamp for MUFP. Laser light was passed through a lens to widen the beam distribution and through a 450 nm, 40 nm bandwidth bandpass filter (Melles Griot). Images were obtained by a cryogenically cooled CH210 CCD camera (Photometrics Ltd., Tucson, Arizona) equipped with a 384×576 pixel TH7882 (Thomson CSF) CCD array and a 50 mm f/1.2 Pentax camera lens stopped down to f/22. Images were collected either through a 450 nm, 40 nm bandwidth bandpass filter (Melles Griot) (MUFP), a 3 mm OG515 (Schott) color filter (5MFP), or a 560 nm, 10 nm bandwidth bandpass filter (Oriel) (BBTP). Full length scans (approximately 24 inches) of the sequence ladders were obtained using TDI mode, which is described in detail below. During scanning, the blot was moved perpendicularly to the camera on a translation stage consisting of a Model 506241S rail table, MD series drive, and a MC. 3000 controller unit(DAEDAL Inc., Harrison City, PA). Two sets of lanes were acquired at 150 dots per inch in 8 minutes of scan time. Image data were downloaded from the camera controller frame buffer to a 286 PC-AT microcomputer, transferred to a Macintosh Quandra for conversion to a TIFF file and lane-finding, and then to a DEC. 5000 workstation for base-calling and sequence analysis, described in detail below.
- In all three cases, sequencing bands were visible to the eye upon illumination within 15 minutes of substrate application. With both MUFP and 5MFP, however, the stuencing ladders, though apparent, were visibly blurred (FIGS. 1A and 1B) even at early time points (65 and 40 minutes, respectively). The blurring is thought to be due to diffusion or bulk flow of the fluorescent product, or both. In contrast, BBTP yielded a relatively sharp ladder, FIG. 1C. Even after prolonged incubation to 20 hours, the sequencing ladder developed with BBTP could be read clearly. It is thought that the fluorescent product, BBT, interacts with the nylon membrane, perhaps through a simple hydrophobic interaction, to inhibit mobility. This property of BBTP, i.e. spatial localization, makes it clearly the most preferable of the substrates tested for sequence determination. MUFP and 5MFP appear to provide sufficient fluorescent product upon dephosphorylation by alkaline phosphatase to be useful for sequencing applications if a method of spatially localizing the fluorescent product could be developed. Similarly, other fluorogenic substrates than the three tested and described here could be used provided the fluorescent product could be bound to the membrane to yield sharply defined bands. The large quantities of light emitted using BBTP as substrate are easily imaged. Further, the fluorescent product, BBT, can be removed from the membrane by washing with detergent, thus making subsequent probing feasible. In this instance, BBT was removed from the membrane by five washes in 5% SDS, 125 mM NaCl, 25 mM sodium phosphate, pH 7.2, for five minutes each at50° C. Other detergents and wash conditions may be suitable, also.
- One of the advantages of generating blots from DNA sequencing gels from run-time transfer to the membrane is the constant band-to-band spacing seen on these blots. The position of sequencing bands on direct transfer electrophoresis blots is approximately linearly related to fragment length. Deviations may occur due to compressions, the inverse wedge profile of the gel, and long term drift in blotting speed. In direct transfer electrophoresis, the band spacing on the membrane, Δs menbrane, is proportional to the blotting speed, vblotting, and to the ratio of the band spacing on the gel, Δgel , to the migration velocity, vmigration . This ratio is equal to the time interval between the elution of two adjacent bands, which is approximately constant over a wide range of fragments covering most of the separated sequencing fragments.
- Direct transfer electrophoresis gives the operator control over the band spacing on the membrane by choosing the appropriate membrane velocity, which is an important feature in the case of subsequent CCD based imaging. It is important to note that while the operator can increase the inter band spacing in direct transfer electrophoresis by increasing the blotting speed, the electrophoretic resolution is not improved by this process. Loss of band resolution due to the limited resolution of the imaging optics is easily prevented by using direct transfer electrophoresis.
- Automated Imaging Hybridization Chamber
- The automated imaging hybridization chamber is an integrated probes to membrane-bound target nucleic acids under controlled conditions. When certain fluorescent probes are used, such as the enzyme-linked probe system using BBTP described above, an image of the nucleic acid on the membrane can be obtained via the transparent window in the outer cylinder without removing the membrane from the chamber compartment. While the chamber system described herein is not limited to a single hybridization chemistry, it was configured specifically for the use of fluorescent probe systems. It was designed, however, to be flexible enough to permit use with other systems. Other probes, such as radioactive probes, could be used in connection with this chamber, but would not utilize the advantage of imaging with the membrane in the chamber. Further, although the hybridization chamber system was designed specifically for sequencing applications, it is capable of handling other membrane-based detection applications such as colony and plaque hybridizations; Southern, Northern and Western blot procedures; multiplex genotyping of simple sequence repeats; sequencing and mapping by hybridization; and dot, slot, and allele-specific oligonucleotide blot techniques. All of the functions of the chamber system are computer controlled and fully definable by the user. The geometry of the chamber device is dictated by a need for the smalles workable fluid volume, for small air volume, to image the pattern of nucleic acid on the membrane, and for accurate temperature control (±2° C.)
- Referring now to FIG. 2, the
chamber device 10 contains two concentric nested horizontal cylinders, an inner sealedcylinder 12 having a continuouscylindrical sidewall 14 and sealed ends 16 and 18, and anouter cylinder 20 having acylindrical sidewall 22 containing a visible lighttransparent window 24 and entry means 26 for gaining access to the exterior surface of thesidewall 14 of the inner drum. Theend 28 ofouter cylinder 20 is also sealed, whereasend 30 can also constitute the entry means 26, in which case end 30 is sealable with an “O” ring positioned betweenend 30 andsidewall 22.Inner cylinder 12 is removable fromouter cylinder 20 through the entry means 26. Themembrane 32 containing bound nucleic acid to be hybridized is mounted on the exterior surface of thesidewall 14 of theinner cylinder 12 with stainless steel wire bails (not shown). Theinner cylinder 12 is rotatable on anaxle 34 such that there is a small clearance (e.g., 0.125 inch) between the outside surface of thesidewall 14 of rotatableinner cylinder 12 and the inside surface of thesidewall 22 of stationaryouter cylinder 20. Thespace 36 between these drum sufaces is referred to as the “chamber compartment.” The clearance between the respective sidewalls of the inner and outer cylinders that defines thechamber compartment 36 should be of sufficient width that theinner cylinder 12 can rotate within theouter cylinder 20 without themembrane 32 coming in contact with the interior surface of theouter cylinder sidewall 22. Disposed on one end of theaxle 34 is a drivengear wheel 38. The mechanism for rotating theinner cylinder 12 includes astepper motor 40 which may be disposed on the outside of theouter cylinder 20 or another stationary object such as a table or machine chassis (not shown). Coupled to thestepper motor 40 is adriving gear wheel 42. Thedriving gear wheel 42 is coupled by atoothed belt 44 to the drivengear wheel 38 mounted on theaxle 34. Thus, when thestepper motor 40 causes thedriving gear wheel 42 to rotate, thebelt 44 is caused to rotate the drivengear wheel 38, which in turn rotates theinner cylinder 12 within theouter cylinder 20. - The hybridization process requires various fluids to be brought into contact with the
membrane 32 in the lower portion ofchamber compartment 36 and then to be removed by drainage from thechamber compartment 36 and replaced by other fluids introduced into thechamber compartment 36. It is crucial that each fluid in thechamber compartment 36 be kept pure and uncontaminated by other fluids. The various fluids are added to or removed from thechamber compartment 36 through a number ofvalves 46 contained inports 48 drilled in the bottom of thecylinder 20. Into eachport 48 is threaded a fluid tight spring loadedcheck valve 46 assembly, FIG. 3. Thesevalves 46 can be actuated by fluid pressure from pumps that deliver the solutions to thechamber compartment 36, by means of solenoids, or the like. The configuration of thevalve assemblies 46 with minimal space 47 (FIG. 3) for holding liquid on the chamber side of the valve when the valve is closed is very significant because of the importance of minimizing the volume of liquid that would be available to contaminate a subsequent step of the process. One embodiment of thechamber device 10 contains 20such ports 48 with associatedvalve assemblies 46; however, the number ofports 48 andvalve assemblies 46 is variable. Thevalve assembly 46 in eachport 48 is connected, via a hose connection end 56 ofvalve assembly 46, to ahose 58 extending from afluid delivery module 82, which will be described in more detail momentarily. Thehoses 58 connectingfluid delivery modules 82 withvalve assemblies 46 contained in thevarious ports 48 have no fluid connection with one another, but may be gathered together in ahose bundle 84 for convenience. Theports 48 are placed in the bottom of the horizontalouter cylinder 20 because it is important for minimizing contamination of succeeding steps in the process that they be located within the fluid puddle 86 (FIG. 4) that accumulates in the lower portion of thechamber compartment 36 when fluid is pumped into thechamber compartment 36 through thevalve assemblies 46 contained inouter cylinder 20. This allows subsequent wash steps to cleansespace 47 in the same way and in the same order that the membrane is treated. As shown in FIG. 4, the volume of thefluid puddle 86 is sufficient to contact themembrane 32 secured to the exterior surface of thesidewall 14 of theinner cylinder 12 when theinner cylinder 12 is rotated. Further, the dead volume in thechamber compartment 36 above thecheck valve assemblies 46 must be kept to a minimum so that the residue from the previous solution is removed in a succeeding washing step and for minimizing the expense connected with the various liquids. One ormore ports 48 serve as drains and containdrain valves 88 configured in any suitable manner so as to be operated manually or automatically under computer control. Whendrain valves 88 are opened, adrain pump 89 pumps spent fluid out of theouter cylinder 20 through drain hoses orlines 90 to adrain reservoir 91. Pneumatic jacks (not shown) assist draining by tilting thechamber device 10 to a position about 5° from horizontal so that the spent fluid accumulates over thedrain valves 88, which are advantageously located near an end of theouter cylinder 20. After draining is completed, the pneumatic jacks return the chamber device 10 a horizontal position. - Mounted on the outside and covering the circumference of the cylindrical sidewall of horizontal
outer cylinder 20, excluding the area occupied bywindow 24 and any entry means if these are different from thewindow 24, is an adhesivefilm heating element 92 for controlling the temperature of the fluids in thechamber compartment 36 and hence the temperature of the environment of the membrane. A thermocouple (not shown) is mounted on the inner surface of theouter cylinder 20 inchamber compartment 36 for monitoring the temperature of thechamber compartment 36 so that the temperature may be regulated as needed by proportional control of theheating element 92. Theheating element 92 and thermocouple are connected to acomputer 94 to provide continuous monitoring and regulation of the temperature. Further description of computer control of thechamber device 10 will be provided momentarily. Theouter cylinder 20 has ends 28 and 30 which make thechamber device 10 virtually airtight so that evaporation or other loss of fluid from thechamber device 10 is minimized during hybridization cycles that may last 12 hours. The small volumes of fluid utilized in making up thefluid puddle 86, e.g., about 50-100 ml in one embodiment of thechamber device 10, are particularly susceptible to even small amounts of fluid loss, especially at elevated temperatures. - The
fluid delivery modules 82 can be made in any suitable form; two forms are illustrated in FIG. 2. The simplest is aconventional metering pump 96 that delivers the larger volumes of relatively inexpensive wash solutions used for washing themembrane 32. These relatively inexpensive solutions are stored inlarge volume reservoirs 98. The more complex type of module involves a double-headedperistaltic pump 100, wherein each head is coupled to the same motor but has a different displacement. This configuration allows thefluid delivery module 82 to mix a relatively small volume of concentrated solution of more expensive and sometimes perishable probe with other solutions These concentrated fluids are stored in probe concentratereservoirs 102 until use, and the other solutions are stored inlarge volume reservoirs 98. In the event that fluids containing perishable components are used, a solid state, proportional control refrigeration unit(not shown) may be coupled to the system for preserving the perishable components from degradation. Certain fluids, for example wash solutions, are more effective at elevated temperatures than at room temperature. These fluids may be heated inside thechamber compartment 36 by theheating element 92. However, this method of heating the solutions causes a time delay that's multiplied by the number of solutions heated. This time delay can be eliminated by preheating the fluids with a proportionalcontrol batch heater 104 installed in the fluid path for heating the fluids just prior to their entry intochamber compartment 36. - The integrated imaging system also advantageously contains an
imaging assembly 106 for obtaining an image of the pattern of hybridization to membrane-bound nucleic acid while themembrane 32 is within thechamber compartment 36. Thesidewall 22 ofouter cylinder 20 contains awindow 24 of optically transparent material through which themembrane 32 mounted on the exterior surface of thesidewall 14 of inner 12 may be visualized. A suitable material for thewindow 24 is LEXAN, although other materials may function equally well. Thewindow 24 may become fogged by condensation within thechamber compartment 36, however theheating element 92 defogs thewindow 24. Optionally, an interior wiper (not shown) can be used to defog thewindow 24. Theimaging apparatus assembly 106 includes alight source 108, such as a laser or a tungsten-halogen lamp with an appropriate band pass filter, tailored to the absorption wavelength of the fluorescent marker and aCCD camera 110 with filter for recording the image. Thelight source 108 is placed an appropriate distance from thechamber device 10 and pointed so that the monochromatic light emitted by thelight source 108 passes through thewindow 24 and illuminates themembrane 32. The fluorescent marker on themembrane 32 is excited by the incident light and emits a fluorescent signal at a characteristic wavelength for the particular fluorescent marker. The fluorescent signal is detectable by theCCD camera 110 placed in a suitable location for observing the emitted fluorescence. Both thelight source 108 and theCCD camera 110 are connected to thecomputer 94 for controlling their operation and storing the data that are collected by theCCD camera 110. Focusing and filtering optics are included in theimaging apparatus 106 for widening the beam distribution and filtering unwanted wavelengths from both the incident light and the fluorescent signal. As shown in FIG. 2, these focusing and filtering optics can include a water-cooledinfrared filter 112 andexcitation bandpass filter 114 combined with thelight source 108 for illuminating themembrane 32, and anemission bandpass filter 116 combined with theCCD camera 110 for removing unwanted background fluorescence and light from theexcitation light source 108.Computer control cables 118 connect thecomputer 94 to each element of the system that's computer controlled:heating element 92,stepper motor 40,metering pump 96, dual headperistaltic pump 100,drain pump 89,light source 108,CCD camera 110, and pneumatic jacks (not shown). - Imaging With CCD Camera
- The full image of fluorescent signals being emitted from a 36×12 inch membrane upon appropriate illumination can be acquired within about 1.5 minutes with a CCD camera operating in TDI mode. Fluorescent images are acquired by a CL-E1-2048-S CCD camera (DALSA Inc., Waterloo, Ontario, Canada) equipped with a 2048×96 pixel IL-EI-2048 TDI array (DALSA). The camera housing is mated to a custom fabricated peltier cooling system, which cools the camera to 0° C. during scanning operations. The analog output of the CCD camera is digitized and written to disk using an AT-MIO-16F-5 Multifunctional I/O board, which is mounted in a 486 PC-AT computer. Intermediate to the CCD camera and the I/O board is a custom designed interface board, which provides compatibility between the camera and the I/O board. Also, the I/O board can generate a trigger signal that's used to shift CCD pixel rows for TDI scanning. A f/1.4 50-mm focal-length Nikon photographic lens is mounted on the camera, and fluorescing membranes are imaged at an approximate distance of 29.5 inches from the lens for 150 dots per inch (dpi) resolution or at about 17 inches for 300 dpi resolution. When generating an image, the membrane mounted to the rotating inner cylinder of the hybridization device is moved across the camera's field of view.
- An area CCD array is composed of two major functional components, a parallel register consisting of a two-dimensional array of light-sensitive CCD elements, and a single-line linear output register, positioned along one side of the parallel register and connected to an on-chip amplifier. Photons striking the CCD surface generate photoelectrons, which are trapped in the CCD element nearest to the location of photon incidence. After the array has been exposed to light, readout of the photo generated charge is performed by simultaneously shifting charge packets of all lines in parallel toward the output register. Having arrived in the output register, the charge packets are shifted one by one in the perpendicular direction toward the on-chip amplifier and subsequent analog to digital conversion.
- When a CCD snapshot is acquired, all photo generated charge packets are read out in an uninterrupted series of parallel transfers followed by serial transfers and digitization after the shutter has closed. No charge transfer takes place during exposure. In TDI mode, in contrast, the parallel shifting of the charge toward the output register is under the control of an external trigger, the TDI trigger. The parallel transfer is delayed until the arrival of a pulse on the time delay trigger line. The controlled transfer of charge is used while the photoactive area is exposed to light and the accumulation of photo generated charge takes place. A line in the resulting TDI image represents light from a line in the object plane that's scanned across the field of view of the camera. This is made possible by synchronizing the image scan speed and the trigger signal, which controls the pixel migration speed. The major advantage of using the TDI mode (also true for line scan mode) is that the number of scan lines is not limited to the number of lines of the parallel register as in standard full-frame operation. The limitations on the length of the TDI scan are determined by the maximum size of the digital storage space, which can be a computer hard disk. A further advantage of TDI mode is its ability to average differences in CCD pixels. Each element of an image is the result of the incremental charge accumulations in the TDI pixels when the image element coincided therewith.
- A TDI scan offers increased sensitivity per unit time when compared to a line scanner equipped with a linear array, because the lights collected simultaneously on the entire photoactive surface of the CCD. Because the sensitivity of a cooled CCD in low-light-level measurements is approximately proportional to the size of the photoactive area, the sensitivity of an area CCD operated in TDI mode is increased over the sensitivity of a linear array consisting of the same time elements approximately by the number of scan lines that are simultaneously monitored. W. Washkurak et al., CCD Image Sensors 198-201 (DALSA Inc., Waterloo, ON, Canada, 1988).
- Automated Gel Reading Software
- An automated sequence reader is used to convert the digital signals acquired by the CCD camera comprising the pattern of fluorescence from the sequencing membrane into a called sequence of nucleotides. The sequence reader used in connection with the automated multiplex sequencing system disclosed herein was a base-calling algorithm described in commonly assigned copending U.S. patent application Ser. No. 07/978,915, filed Nov. 19, 1992, entitled METHODS AND APPARATUS FOR ANALYSIS OF CHROMATOGRAPHIC MIGRATION PATTERNS, and hereby incorporated by reference. Other automated sequence readers are commercially available and could be used in the presently described system, such as those by ABI, Pharmacia, Milligen, Hitachi, and LiC. or.
- A full length image of the BBTP membrane, 40 minutes after addition of substrate, shown in FIG. 1C was acquired with a CCD camera operating in TDI mode and was processed using the automatic gel reading software of serial no. 07/978,915 modified to accept a positive fluorescent image rather than a negative one as is usual with imaging on X-ray film. FIG. 5 shows a portion of the unprocessed one-dimensional traces, obtained by averaging horizontally across several pixels at the lane centers. The BBTP membrane was up-sampled by a factor of two to produce a 300 dots-per-inch image expected by the gel reader. Lanes were found manually using a Macintosh program, and the data shown were produced by averaging the value of 15 pixels per row around the lane centers. The individual traces have not been processed in FIG. 5, but the traces have been slightly shifted relative to one another to obtain better alignment.
- The automated reader yielded reasonably accurate sequence as far as the membrane was imaged, 653 nucleotides from the primer. There were 8 total errors (7 deletions and one substitution) in the 581 nucleotides deciphered, for an error rate of 1.4%. The first error occurred 381 nucleotides from the primer. Four of the eight errors occurred within the last 39 nucleotides and two of the remaining errors were due to compression and false stop artifacts.
- Utility
- The utility of the automated multiplex sequencing system was shown by sequencing a 10.5 kb plasmid subclone of the human neurofibromatosis I genomic locus. Template DNA was prepared from a mapped set of 480-nucleotide sequencing transposon inserts. The transposon carries a NotI site, used for mapping and biotinylation, and two multiplex priming sites, one at each end of the element. Plasmid DNA (1 pmol) from each template was prepared by the alkaline lysis method, J. Sambrook et al., Molecular Cloning: A Laboratory Manual 1.25 (2d ed., 1989), which is hereby incorporated by reference. Then, the DNA was digested with NotI according to the instructions of the manufacturer, and the NotI site was filled in with bio-11-dCTP (Enzo Diagnostics) using the Klenow fragment of E. coli DNA polymerase I. Next the DNA was digested with EcoRI at sites flanking the inserted DNA and the biotinylated insert DNA was bound to 0.5 mg of M280 streptavidin dynabeads (Dynal, Glen Cove, N.Y.). The bead-bound DNA was then converted to single-stranded template by denaturation with 0.2 N NaOH and the template was subjected to a sequencing reaction as described above except that a magnet was used to concentrate the bound DNA after the reactions were terminated. Dynabeads have an iron component that permits magnetic concentration of the beads and the bound DNA-Sequencing reaction products were loaded on a 4% polyacrylamide gel and subjected to electrophoresis as described in Example 1. Fractionated DNA fragments were directly transferred to a nylon membrane using the custom direct transfer apparatus described above. The membrane was removed from the apparatus, rehydrated in 40 mM sodium phosphate buffer, pH 7.6, and irradiated with a total of 225 mJ/cm2 of UV light to cross link the DNA fragments to the nylon membrane. Unbound DNA was removed by washing the membrane in PBS (40 mM sodium phosphate, pH 7.6, 150 mM NaC. I), 5% SDS, and then the membrane was placed in the automated imaging hybridization chamber. The controller was programmed for automatic operation and the steps described below proceeded automatically in a cycle time of 4.5 hours.
- Hybridization of a probe specific for one of the two multiplex priming sites was begun by injecting 50 ml of pre-hybridization buffer (PBS +5% SDS) into the chamber compartment by means of the fluid delivery module. The rotation of the inner cylinder was set to sweep a bead of fluid across the concave survace of the membrane at approximately 20 second intervals. Pre-hybridization was at50° C. for 30 minutes. Then, the 24-mer oligonucleotide probe was injected to a concentration of 25 pmol/ml. The probe was 3′ end labeled with digoxigenin-11-dUTP and dATP in a 1:10 ratio. Hybridization was carried out for 120 minutes. Then, the hybridization buffer was removed by automatic opening of a drain valve and draining through a drain hose. The drain valve was closed and then wash buffer (PBS+5% SDS) was injected into the chamber by the fluid delivery module. Unhybridized probe was removed by 8 washes, each in 100 ml of wash buffer for 5 minutes at 50° C. Between washes, the wash buffer was drained by opening of a drain valve and draining through a drain hose, and then the drain valve was closed. After A removal of the unhybridized probe was completed, a 1/5000 dilution of anti-digoxigenin antibody-alkaline phosphatase conjugate (Boehringer Mannheim) was injected into the chamber compartment by the fluid delivery module in a total volume of 40 ml of PBS containing 5% SDS and was allowed to bind to the by digoxigenin-derivatized probe for 45 minutes at 24° C. Then, the conjugate solution was drained and unbound conjugate was removed by 1 wash with PBS, 5% SDS; 1 wash with PBS, 1 SDS; 3 washes with PBS; and 3 washes with 0.1 M diethanolamine, pH 10.0, 1 mM MgCl 2 , 0.01 % sodium azide.
- The alkaline phosphatase reaction was begun by draining the last wash solution and then adding 50 ml of BBTP solution (6 mg/ml in 2.4 mM diethanolamine, pH 9.0). After 180 minutes, fluorescence emission was excited by the 458 nm line of an argon I ion laser (Lexel Model 96). The laser beam was passed through a lens to widen beam distribution and through a 450 nm, 40 nm band width, bandpass filter (Melles Griot). Images were obtained with a cryogenically cooled C. H210 CCD camera (Photometrics), equipped with a 384×576 pixel TH7882 (Thomson) CCD array and a 50 mm f/1.2 Pentax camera lens stopped down to f/22. Images were collected through a 560 nm, 10 nm bandwidth, bandpass filter (Oriel). Full length scans of the sequence ladders were obtained in TDI mode. During scanning, the membrane was moved perpendicularly to the camera by synchronized movement of a stepper motor-driven translation stage to which the membrane was mounted, as controlled by the computer controller. Two lane sets were acquired at 150 dots per inch in 8 minutes of scan time. Image data were transferred to a MacIntosh Quadra for conversion to a TIFF file and lane-finding, and then to a DEC. 5000 workstation for base-calling and sequence analysis.
- After acquisition of the data from probing with the first probe, the fluorescent product generated from the first probing was easily removed by a brief detergent wash consisting of five washes for 5 minutes each in PBS containing 5% SDS at 50° C. The steps of hybridization, binding of the enzyme conjugate, enzyme reaction, and data acquisition were repeated with a second probe. The membrane contained 10 sets of sequencing lanes, each of which contained a two-fold multiplexed sequence ladder. Two probings of this membrane generated sequence ladders from 18 of the sets of lanes, yielding 5841 nucleotides, or an average of about 325 nucleotides per set. The membrane was then subjected to a third round of hybridization using the probe used in the first hybridization, and ladders corresponding to the initial probing were reacquired with comparable quality.
- The same procedure is used as in Example 5 with the exception that images are obtained with a peltier cooled DALSA CL-E1-2048-S CCD camera equipped with a DALSA 2048×96 pixel IL-E1-2048 array connected to a 486 PC-AT computer via an AT-MIO-16F-5 National Instruments board that converts the camera's analog signal to digital and writes the data directly to disk. Further, the membrane remains mounted on the inner cylinder of the chamber device and the membrane is moved perpendicularly to the camera by synchronized movement of the inner cylinder by the stepper motor, as controlled by the computer controller. Full length images are acquired in 1.5 minutes of scan time.
- The sensitivity, detection limits, and efficiency of hybridization with the automatic multiplex sequence system was estimated as follows. A range of quantities of unlabeled and biotinylated 75-mer oligonucleotides were subjected to electrophoresis in a sequencing gel and then transferred to a membrane filter as described above. Unlabeled DNA was probed with a singly biotinylated oligonucleotide, but biotinylated DNA was not probed. The membrane was then exposed to streptavidin-alkaline phosphatase conjugate, followed by addition of BBTP. The membrane was illuminated and imaged at three time points, as shown in FIGS. 6 and 7. Signal levels were approximately linear with time and quantity. Signal intensities were higher when biotinylated DNA was detected (FIG. 6) than when unlabeled DNA was later biotinylated and detected (FIG. 7). There was a two-to three-fold difference in intensity, presumably due to incomplete binding of the DNA to the membrane, effective loss of target DNA due to cross linking and steric factors, incomplete hybridization of biotinylated probe to bound target DNA, or A, combinations thereof. Limits of detection, defined as the quantity of DNA yielding a peak height equal to three times the standard deviation of the background, are calculated from least-squares estimates of the slopes of the lines. At 1 and 4 hours after application of the substrate, the limits of detection for a single biotin are 5 and 1 attomoles (10 −10 moles) for direct detection and 14 and 2 attomoles for a hybridized probe, respectively. Quantities of sequencing template in the 0.5 pmol range typically yield a few hundred attomoles of dideoxy-terminated chain per band. Thus, the technique described herein has the sensitivity required for low-level multiplexing (<10 reprobings), and the use of probes with multiple biotin molecules or the use of various amplification schemes should increase the signal further and allow for deep levels of multiplexing.
- The background signal in these measurements consists of three components: intrinsic membrane fluorescence, substrate fluorescence, and fluorescence of product generated from non-specifically bound DNA or streptavidin-alkaline phosphatase or both. Initially, membrane fluorescence dominates the background signal, as determined by fluorescent measurements on membranes with and without substrate. At later times, fluorescent product due to non-specific enzyme binding can become the major background component. This same background limits enzyme-linked chemiluminescent measurements and is very sensitive to probing, wash conditions, and the physical handling of the membrane, as can be seen from its macroscopic inhomogeneity. Integration of automated probing and detection cycles, as well as alternate probing schemes, may help to minimize this type of background. The background signal due to membrane fluorescence could be decreased by the use of a low fluorescence membrane, T. Chu et al., 13 Electrophoresis 105 (1992); U.S. Pat. No. 5,112,736, or by the development of fluorogenic substrates whose products excite in the near-infrared, where intrinsic membrane fluorescence may be lessened. Any such change of materials would have to preserve the postulated membrane/product interaction, as well as low substrate fluorescence and low non-specific binding of the enzyme conjugate.
- The fluorescent signal is greater than comparable chemiluminescent signals by a factor of more than 10 5. The absolute intensity of the signal is more than sufficient for imaging. To avoid saturation of the CCD during TDI scanning of the sequence ladders, the camera lens was stopped down to f/22, which decreases the light intensity by a factor of 336 compared to the largest aperture, f/1.4, and neutral density filters were frequently required. Increase of the excitation light could increase the signal intensity further by several orders of magnitude. Even though the absolute signal intensity is sufficient for simple detection, increases in signal-to-noise ratio would still be desirable, and there may be much room for improvement. BBT was excited with 458 nm light because the argon laser was a convenient light source. BBT excites maximally near 430 nm, and the excitation peak is approximately twice the value of 458 nm, thus a two-fold improvement in sensitivity might be achieved by a change in excitation wavelength. While the details of emission filtering were not found to be extremely critical, a more careful optimization of the optics might be fruitful.
Claims (82)
1. A method for sequencing a nucleic acid specimen by automated multiplex sequencing comprising the steps of:
(a) preparing multiplex sequencing reaction products including at least one tag sequence in a plurality of vessels, wherein said products in each vessel differ in length from each other and all terminate at a fixed known nucleotide or nucleotides, wherein said fixed known nucleotide or nucleotides in one of said vessels differ from said fixed known nucleotide or nucleotides in another of said vessels;
(b) fractionating said products from each said vessel according to their size;
(c) attaching said fractionated products from each said vessel to a membrane;
(d) placing said membrane containing said fractionated products in a chamber device of an integrated automated imaging hybridization chamber system comprising an hybridization chamber device, means for fluid delivery to said chamber device, imaging means for light delivery to said membrane and image recording of fluorescence emanating from said membrane while in said chamber device, and controller means for controlling operation of said system;
(e) introducing a first oligonucleotide probe containing a binding moiety to which an enzyme may be bound and which is able to hybridize specifically with one of said tag sequences into said chamber device by said fluid delivery means and bringing said probe into contact with said membrane thereby hybridizing said probe to said fractionated products;
(f) introducing an enzyme into said chamber device by said fluid delivery means and bringing said enzyme into contact with said first oligonucleotide probe thereby binding the enzyme to said binding moiety on said first oligonucleotide probe;
(g) introducing a fluorogenic substrate into said chamber device by said fluid delivery means and bringing said substrate into contact with said enzyme, wherein said enzyme converts said fluorogenic substrate into a fluorescent product and wherein the fluorescent product interacts with the membrane and is spatially localized thereon;
(h) illuminating said fluorescent product in said chamber device with a beam of light from said imaging means capable of exciting fluorescence by said fluorescent product, wherein said fluorescence produces a pattern of hybridization that reflects the nucleotide sequence of said nucleic acid specimen;
(i) imaging said pattern of hybridization by said imaging means, wherein said pattern of hybridization is stored as a series of digital signals; and
(j) converting said series of digital signals by said controller means into a linear string of nucleotides corresponding to the nucleotide sequence of the nucleic acid specimen.
2. The method of claim 1 further comprising
(k) removing the fluorescent product from the membrane by introducing an appropriate wash solution into the chamber compartment by the fluid delivery means and removing the wash solution from the chamber compartment by means for fluid removal from said chamber compartment via valve means contained in the lower portion of said outer cylinder sidewall;
(l) introducing a second oligonucleotide probe, containing a binding moiety to which an enzyme may be bound and which is able to hybridize specifically with one of said tag sequences different than the tag sequence of step (e), into said chamber device by said fluid delivery means and bringing said second oligonucleotide probe into contact with said membrane, thereby hybridizing said second probe to said fractionated products;
(m) introducing an enzyme into said chamber device by said fluid delivery means and bringing said enzyme into contact with said second oligonucleotide probe, thereby binding the enzyme to said binding moiety on said second oligonucleotide probe; and
(n) repeating steps (g) through (j).
3. The method of claim 1 wherein step (b) further comprises fractionating said products by gel electrophoresis.
4. The method of claim 3 wherein step (c) further comprises transferring said fractionated products to said membrane by electrophoresis.
5. The method of claim 4 wherein said electrophoresis is direct transfer electrophoresis.
6. The method of claim 1 wherein the hybridization chamber device used in step (d) comprises
generally horizontal, concentrically nested inner and outer cylinders having a common axis,
the inner cylinder consisting of a cylindrical sidewall having an exterior surface and sealed ends, said inner cylinder being rotatable about said axis,
the outer cylinder consisting of a stationary cylindrical sidewall having interior and exterior surfaces, a transparent window contained therein and having sealable ends,
said inner cylinder being rotatable within said outer cylinder about said axis, said membrane being mounted on the exterior sidewall surface of said inner cylinder;
said inner and outer cylinders having diameters such that there is a space between the respective sidewalls of said inner and outer cylinders defining a chamber compartment of sufficient width that said inner cylinder can rotate within said outer cylinder without said membrane coming in contact with the interior surface of said outer cylinder sidewall,
said chamber compartment being in fluid communication with said means for fluid delivery via valve means contained in a lower portion of said outer cylinder sidewall.
7. The method of claim 6 wherein said hybridization chamber device further comprises means for rotating said inner cylinder.
8. The method of claim 7 wherein said rotating means comprises a stepper motor.
9. The method of claim 6 wherein said fluid delivery means comprises a plurality of reservoirs for storing fluids and metering pumps for delivering fluid in selectable volumes.
10. The method of claim 9 wherein said fluid delivery means further comprises a batch heater for heating said fluids to a selected temperature before said fluids are delivered to said chamber compartment.
11. The method of claim 9 wherein said fluid delivery means further comprises a probe concentrate reservoir for storing a concentrated liquid hybridization probe and the like, and means for mixing said concentrated hybridization probe and a fluid to form a hybridization solution and delivering said hybridization solution to said chamber compartment.
12. The method of claim 11 wherein said fluid delivery means further comprises means for chilling said hybridization probe.
13. The method of claim 6 wherein said hybridization chamber device further comprises aheating element for heating a fluid contained in said chamber compartment to a selected temperature.
14. The method of claim 13 wherein said hybridization chamber device further comprises a thermocouple for monitoring the temperature of a fluid contained in said chamber compartment.
15. The method of claim 6 further comprising means for fluid removal from said chamber compartment via valve means contained in the lower portion of said outer cylinder sidewall.
16. The method of claim 6 wherein said imaging means includes a light source for producing and delivering a beam of light of an appropriate wavelength to the membrane for exciting fluorescence of said fluorescent product.
17. The method of claim 16 wherein said light source comprises a laser.
18. The method of claim 16 wherein said light source comprises a tungsten-halogen lamp with a band pass filter.
19. The method of claim 16 wherein said imaging means further comprises a filter for removing undesirable wavelengths of light from said beam of light.
20. The method of claim 16 wherein said imaging means includes a CCD camera for recording an image of said fluorescence emanating from said fluorescent product on said membrane and a filter for removing interfering wavelengths of light from said fluorescence of said fluorescent product.
21. The method of claim 20 wherein said CCD camera is operable in Time Delay and Integration mode.
22. The method of claim 1 wherein step (f) further comprises attaching to said enzyme a molecule having an affinity for binding to said binding moiety, said molecule forming a bridge for binding of said enzyme to said binding moiety.
23. The method of claim 22 wherein said binding moiety comprises a biotin molecule covalently attached to said probe and said bridging molecule is selected from the group consisting of streptavidin and avidin.
24. The method of claim 22 wherein said binding moiety comprises a digoxigenin molecule covalently attached to said probe and said bridging molecule comprises an anti-digoxigenin antibody.
25. The method of claim 1 wherein the enzyme of step (f) is alkaline phosphatase.
26. The method of claim 1 wherein the fluorogenic substrate of step (g) is a phosphorylated benzothiazole derivative.
27. The method of claim 26 wherein the fluorogenic substrate is BBTP.
28. The method of claim 1 wherein step (i) further comprises scanning the full length of the membrane.
29. The method of claim 28 wherein said membrane is moved in synchrony with the scanning of the membrane, said movement actuated by the stepper motor coupled to the inner cylinder of the hybridization chamber device and controlled by the controller means.
30. The method of claim 1 wherein step (j) comprises converting said digital signals into a linear string of nucleotides corresponding to the nucleotide sequence of the nucleic acid specimen by an automated sequence reader.
31. An integrated automated imaging hybridization chamber system for sequencing a nucleic acid specimen by automated multiplex sequencing comprising an hybridization chamber device for mounting a membrane containing fractionated multiplex sequencing reaction products, means for fluid delivery to said chamber device, imaging means for light delivery to said membrane and image recording of fluorescence emanating from said membrane while in said chamber device, and controller means for controlling operation of the system.
32. The system of claim 31 wherein the hybridization chamber device comprises
generally horizontal, concentrically nested inner and outer cylinders having a common axis,
the inner cylinder consisting of a cylindrical sidewall having an exterior surface and sealed ends, said inner cylinder being rotatable about said axis,
the outer cylinder consisting of a stationary cylindrical sidewall having interior and exterior surfaces, a transparent window contained therein and having sealable ends,
said inner cylinder being rotatable within said outer cylinder about said axis, said membrane being mounted on the exterior sidewall surface of said inner cylinder;
said inner and outer cylinders having diameters such that there is a space between the respective sidewalls of said inner and outer cylinders defining a chamber compartment of sufficient width that said inner cylinder can rotate within said outer cylinder without said membrane coming in contact with the interior surface of said outer cylinder sidewall, said chamber compartment being in fluid communication with
said means for fluid delivery via valve means contained in the lower portion of said outer cylinder sidewall.
33. The system of claim 32 wherein said hybridization chamber device further comprises means for rotating said inner cylinder.
34. The system of claim 33 wherein said rotating means comprises a stepper motor.
35. The system of claim 32 wherein said fluid delivery means comprises a plurality of reservoirs for storing fluids and metering pumps for delivering fluid in selectable volumes.
36. The system of claim 35 wherein said fluid delivery means further comprises a batch heater for heating said fluids to a selected temperature before said fluids are delivered to said chamber compartment.
37. The system of claim 35 wherein said fluid delivery means further comprises a probe concentrate reservoir for storing a concentrated liquid hybridization probe and the like, and means for mixing said concentrated hybridization probe and a fluid to form a hybridization solution and delivering said hybridization solution to said chamber compartment in a selectable volume.
38. The system of claim 37 wherein said fluid delivery means further comprises means for chilling said hybridization probe.
39. The system of claim 32 wherein said hybridization chamber device further comprises an adhesive film heating element for heating a fluid contained in said chamber compartment to a selected temperature, wherein said heating element is coupled to the exterior surface of the sidewall of the outer cylinder.
40. The system of claim 39 wherein said hybridization chamber device further comprises a thermocouple for monitoring the temperature of fluid contained in said chamber compartment.
41. The system of claim 32 further comprising means for fluid removal from said chamber compartment via valve means contained in the lower portion of said outer cylinder sidewall.
42. The system of claim 32 wherein said imaging means includes a light source for producing and delivering a beam of light of an appropriate wavelength to the membrane for exciting fluorescence of said fluorescent product.
43. The system of claim 42 wherein said light source is selected from the group consisting of a laser and a tungsten-halogen lamp with a band pass filter.
44. The system of claim 43 wherein said imaging means further comprises a filter for removing undesirable wavelengths of light from said beam of light.
45. The system of claim 42 wherein said imaging means includes a CCD camera for recording an image of said fluorescence emanating from said fluorescent product on said membrane and a filter for removing interfering wavelengths of light from said fluorescence of said fluorescent product.
46. The system of claim 45 wherein said CCD camera is operable in Time Delay and Integration mode.
47. The system of claim 31 wherein the controller means is a programmable computer.
48. A method for enzyme-linked fluorescent detection of nucleic acid comprising the steps of:
(a) attaching the nucleic acid to be detected to a membrane;
(b) contacting the membrane with an oligonucleotide probe containing a binding moiety for binding an enzyme and which is able to hybridize specifically with a complementary sequence on the nucleic acid, thereby hybridizing said probe to said nucleic acid;
(c) contacting the probe with an enzyme thereby binding the enzyme to said binding moiety on the probe;
(d) contacting the enzyme with a fluorogenic substrate so that the enzyme converts the fluorogenic substrate into a fluorescent product, wherein the fluorescent product interacts with the membrane and is spatially localized thereon; and
(e) illuminating said fluorescent product with a beam of light capable of exciting fluorescence by said fluorescent product, wherein said fluorescence produces a pattern of hybridization that reflects the location of said nucleic acid on said membrane.
49. The method of claim 48 wherein said membrane is comprised of nylon.
50. The method of claim 48 wherein step (c) further comprises attaching to said enzyme a molecule having an affinity for binding to said binding moiety, said molecule forming a bridge for binding of said enzyme to said binding moiety.
51. The method of claim 50 wherein said binding moiety comprises a biotin molecule covalently attached to said probe and said bridging molecule is selected from the group consisting of streptavidin and avidin.
52. The method of claim 50 wherein said binding moiety comprises a digoxigenin molecule covalently attached to said probe and said bridging molecule comprises an anti-digoxigenin antibody.
53. The method of claim 50 wherein the enzyme is alkaline phosphatase.
54. The method of claim 53 wherein the fluorogenic substrate is a phosphorylated benzothiazole derivative.
55. The method of claim 54 wherein the fluorogenic substrate is BBTP.
56. The method of claim 50 further comprising
(f) imaging said pattern of hybridization by imaging means.
57. The method of claim 56 wherein said imaging means includes a light source for producing and delivering a beam of light of an appropriate wavelength to the membrane for exciting fluorescence of said fluorescent product.
58. The method of claim 57 wherein said light source is selected from the group consisting of a laser and a tungsten-halogen lamp with a band pass filter.
59. The method of claim 57 wherein said imaging means further comprises a filter for removing undesirable wavelengths of light from said beam of light.
60. The method of claim 57 wherein said imaging means includes a CCD camera for recording an image of said fluorescence emanating from said fluorescent product on said membrane and a filter for removing interfering wavelengths of light from said fluorescence of said fluorescent product.
61. The method of claim 60 wherein said CCD camera is operable in Time Delay and Integration mode.
62. A hybridization chamber device for hybridizing a probe to a nucleic acid bound to a membrane comprising
generally horizontal, concentrically nested inner and outer cylinders having a common axis,
the inner cylinder consisting of a cylindrical sidewall having an exterior surface and sealed ends, said inner cylinder being rotatable about said axis,
the outer cylinder consisting of a stationary cylindrical sidewall having interior and exterior surfaces,
a transparent window contained therein and having sealable ends,
A said inner cylinder being rotatable within said outer cylinder about said axis, said membrane being mounted on the exterior sidewall surface of said inner cylinder;
said inner and outer cylinders having diameters such that a there is a space between the respective sidewalls of said inner and outer cylinders defining a chamber compartment of sufficient width that said inner cylinder can rotate within said outer cylinder without said membrane coming in contact with the interior surface of said outer cylinder sidewall.
63. The hybridization chamber device of claim 62 wherein said hybridization chamber device further comprises means for rotating said inner cylinder.
64. The hybridization chamber device of claim 63 wherein said rotating means comprises a stepper motor.
65. The hybridization chamber device of claim 62 wherein said hybridization chamber device further comprises a heating element for heating a fluid contained in said chamber compartment to a selected temperature.
66. The hybridization chamber device of claim 69 wherein said hybridization chamber device further comprises a thermocouple for monitoring the temperature of a fluid contained in said chamber compartment.
67. The hybridization chamber device of claim 65 wherein said heating element is a film contained on the exterior surface of the said wall of the outer cyliner.
68. The hybridization chamber device of claim 62 further comprising means for fluid delivery, said chamber compartment being in fluid communication with said means for fluid delivery via valve means contained in a lower portion of said outer cylinder sidewall, wherein said fluid delivery means comprises a plurality of reservoirs for storing fluids and metering pumps for delivering fluid in selectable volumes.
69. The hybridization chamber device of claim 68 wherein said fluid delivery means further comprises a batch heater for heating said fluids to a selected temperature before said fluids are delivered to said chamber compartment.
70. The hybridization chamber device of claim 68 wherein said fluid delivery means further comprises a probe concentrate reservoir for storing a concentrated liquid hybridization probe and the like, and means for mixing said concentrated hybridization probe and a fluid to form a hybridization solution and delivering said hybridization solution to said chamber compartment.
71. The hybridization chamber device of claim 70 wherein said fluid delivery means further comprises means for chilling said hybridization probe.
72. The hybridization chamber device of claim 62 further comprising means for fluid removal from said chamber compartment via valve means contained in the lower portion of said outer cylinder sidewall.
73. The hybridization chamber device of claim 62 wherein said hybridization chamber device further comprises imaging means for light delivery to said membrane and image recording of fluorescence emanating from said membrane while in said hybridization chamber device, wherein said imaging means includes a light source for producing and delivering a beam of light of an appropriate wavelength to the membrane for exciting fluorescence of said fluorescent product.
74. The hybridization chamber device of claim 73 wherein said light source is selected from the group consisting of laser and a tungsten-halogen lamp with a band pass filter.
75. The hybridization chamber device of claim 74 wherein said imaging means further comprises a filter for removing undesirable wavelengths of light from said beam of light.
76. The hybridization chamber device of claim 73 wherein said imaging means includes a CCD camera for recording an image of said fluorescence emanating from said fluorescent product on said membrane and a filter for removing interfering wavelengths of light from said fluorescence of said fluorescent product.
77. The hybridization chamber device of claim 76 wherein said CCD camera is operable in Time Delay and Integration mode.
78. A method for detecting a macromolecule bound to a membrane comprising the steps of:
(a) preparing a sample of the macromolecule and attaching the macromolecule to a membrane;
(b) placing said membrane containing said macromolecule in a chamber device of an integrated automated imaging hybridization chamber system comprising an hybridization chamber device, means for fluid delivery to said chamber device, imaging means for light delivery to said membrane and image recording of fluorescence emanating from said membrane while in said chamber device, and controller means for controlling operation of said system;
(c) introducing a probe containing a binding moiety to which an enzyme may be bound and which is able to bind specifically with said macromolecule into said chamber device by said fluid delivery means and bringing said probe into contact with said membrane thereby binding said probe to said macromolecule;
(d) introducing an enzyme into said chamber device by said fluid delivery means and bringing said enzyme into contact with said probe thereby binding the enzyme to said binding moiety on said probe;
(e) introducing a fluorogenic substrate into said chamber device by said fluid delivery means and bringing said substrate into contact with said enzyme, wherein said enzyme converts said fluorogenic substrate into a fluorescent product and wherein the fluorescent product interacts with the membrane and is spatially localized thereon;
(f) illuminating said fluorescent product in said chamber device with a beam of light from said imaging means capable of exciting fluorescence by said fluorescent product, wherein said fluorescence produces a pattern of binding that reflects the location on said membrane of said macromolecule; and
(g) imaging said pattern of binding by said imaging means, wherein said pattern of binding is stored as digital signals.
79. The method of claim 78 wherein said macromolecule is a nucleic acid.
80. The method of claim 79 wherein step (a) is selected from the group consisting of colony hybridization, plaque hybridization, Southern hybridization, Northern hybridization, multiplex genotyping of simple sequence repeats, sequencing by hybridization, gene mapping by hybridization, dothybridization, slot hybridization, and allele-specific oligonucleotide blot hybridization.
81. The method of claim 78 wherein said macromolecule is a protein.
82. The method of claim 81 wherein step (a) comprises Western blotting.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/563,462 US20020012910A1 (en) | 1993-10-22 | 1995-11-28 | Automated hybridization/imaging device for fluorescent multiplex dna sequencing |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/141,234 US5470710A (en) | 1993-10-22 | 1993-10-22 | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing |
| US08/563,462 US20020012910A1 (en) | 1993-10-22 | 1995-11-28 | Automated hybridization/imaging device for fluorescent multiplex dna sequencing |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/141,234 Division US5470710A (en) | 1993-10-22 | 1993-10-22 | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20020012910A1 true US20020012910A1 (en) | 2002-01-31 |
Family
ID=22494783
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/141,234 Expired - Lifetime US5470710A (en) | 1993-10-22 | 1993-10-22 | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing |
| US08/563,462 Abandoned US20020012910A1 (en) | 1993-10-22 | 1995-11-28 | Automated hybridization/imaging device for fluorescent multiplex dna sequencing |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/141,234 Expired - Lifetime US5470710A (en) | 1993-10-22 | 1993-10-22 | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5470710A (en) |
| EP (1) | EP0724627A4 (en) |
| AU (1) | AU8122294A (en) |
| CA (1) | CA2174779A1 (en) |
| WO (1) | WO1995011961A1 (en) |
Cited By (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020001803A1 (en) * | 1999-07-20 | 2002-01-03 | Smith Douglas H. | Method for contacting fluid components with moieties on a surface |
| US20050014175A1 (en) * | 1999-06-28 | 2005-01-20 | California Institute Of Technology | Methods and apparatuses for analyzing polynucleotide sequences |
| US20050032076A1 (en) * | 1998-05-01 | 2005-02-10 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| US20050130183A1 (en) * | 2003-12-10 | 2005-06-16 | Oh Kwang-Wook | Real-time PCR monitoring apparatus and method |
| US6913931B2 (en) | 2002-10-03 | 2005-07-05 | 3M Innovative Properties Company | Devices, methods and systems for low volume microarray processing |
| US20050164281A1 (en) * | 2003-12-10 | 2005-07-28 | Oh Kwang-Wook | Polymerase chain reaction (PCR) module and multiple PCR system using the same |
| US20050170367A1 (en) * | 2003-06-10 | 2005-08-04 | Quake Stephen R. | Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids |
| US20050239085A1 (en) * | 2004-04-23 | 2005-10-27 | Buzby Philip R | Methods for nucleic acid sequence determination |
| US20060019263A1 (en) * | 1999-06-28 | 2006-01-26 | Stephen Quake | Methods and apparatuses for analyzing polynucleotide sequences |
| US20060019276A1 (en) * | 2004-05-25 | 2006-01-26 | Timothy Harris | Methods and devices for nucleic acid sequence determination |
| EP1541237A3 (en) * | 2003-12-10 | 2006-02-01 | Samsung Electronics Co., Ltd. | Polymerase chain reaction (pcr) module and multiple pcr system using the same |
| US20060024678A1 (en) * | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
| US20060046258A1 (en) * | 2004-02-27 | 2006-03-02 | Lapidus Stanley N | Applications of single molecule sequencing |
| US20060118754A1 (en) * | 2004-12-08 | 2006-06-08 | Lapen Daniel C | Stabilizing a polyelectrolyte multilayer |
| US20060147901A1 (en) * | 2003-07-02 | 2006-07-06 | Greve Jan | Devices and methods to image objects by time delay integration |
| US20060172313A1 (en) * | 2005-01-28 | 2006-08-03 | Buzby Philip R | Methods and compositions for improving fidelity in a nucleic acid synthesis reaction |
| US20060172328A1 (en) * | 2005-01-05 | 2006-08-03 | Buzby Philip R | Methods and compositions for correcting misincorporation in a nucleic acid synthesis reaction |
| US20060172408A1 (en) * | 2003-12-01 | 2006-08-03 | Quake Steven R | Device for immobilizing chemical and biochemical species and methods of using same |
| US20060252077A1 (en) * | 2004-12-30 | 2006-11-09 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
| US20060263790A1 (en) * | 2005-05-20 | 2006-11-23 | Timothy Harris | Methods for improving fidelity in a nucleic acid synthesis reaction |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US20070117102A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
| US20070117104A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
| US20070117103A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
| US20070128610A1 (en) * | 2005-12-02 | 2007-06-07 | Buzby Philip R | Sample preparation method and apparatus for nucleic acid sequencing |
| US20070128614A1 (en) * | 2005-12-06 | 2007-06-07 | Liu David R | Nucleotide analogs |
| US7297518B2 (en) | 2001-03-12 | 2007-11-20 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
| US20080052951A1 (en) * | 2005-04-28 | 2008-03-06 | Mabe Canada Inc. | Apparatus and method for controlling a clothes dryer |
| US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
| EP1656545A4 (en) * | 2003-08-11 | 2010-06-09 | Immunivest Corp | DEVICES AND METHODS FOR IMAGING OBJECTS BY INTEGRATION IN TIME |
| US20100311070A1 (en) * | 2003-12-10 | 2010-12-09 | Samsung Electronics Co., Ltd. | Polymerase chain reaction (pcr) module and multiple pcr system using the same |
| US20110045493A1 (en) * | 2008-08-18 | 2011-02-24 | Millipore Corporation | Hydrophilic, High Protein Binding, Low Fluorescence, Western Blotting Membrane |
| US7981604B2 (en) | 2004-02-19 | 2011-07-19 | California Institute Of Technology | Methods and kits for analyzing polynucleotide sequences |
| US20110183321A1 (en) * | 1998-05-01 | 2011-07-28 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| US20120196296A1 (en) * | 2001-07-25 | 2012-08-02 | Life Technologies Corporation | DNA Sequencing System |
| CN108700520A (en) * | 2016-02-26 | 2018-10-23 | 辛格科技公司 | Method and apparatus for high-throughput imaging |
Families Citing this family (177)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
| WO1994016104A1 (en) * | 1993-01-08 | 1994-07-21 | Ctrc Research Foundation | Color imaging system for use in molecular biology |
| US6750011B1 (en) * | 1994-06-17 | 2004-06-15 | Mark W. Perlin | Method and system for genotyping |
| US6600996B2 (en) | 1994-10-21 | 2003-07-29 | Affymetrix, Inc. | Computer-aided techniques for analyzing biological sequences |
| US5795716A (en) * | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
| US5733729A (en) * | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
| US20040175718A1 (en) * | 1995-10-16 | 2004-09-09 | Affymetrix, Inc. | Computer-aided visualization and analysis system for sequence evaluation |
| US5830657A (en) * | 1996-05-01 | 1998-11-03 | Visible Genetics Inc. | Method for single-tube sequencing of nucleic acid polymers |
| US6613508B1 (en) | 1996-01-23 | 2003-09-02 | Qiagen Genomics, Inc. | Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
| US6312893B1 (en) | 1996-01-23 | 2001-11-06 | Qiagen Genomics, Inc. | Methods and compositions for determining the sequence of nucleic acid molecules |
| US6027890A (en) | 1996-01-23 | 2000-02-22 | Rapigene, Inc. | Methods and compositions for enhancing sensitivity in the analysis of biological-based assays |
| US6361937B1 (en) | 1996-03-19 | 2002-03-26 | Affymetrix, Incorporated | Computer-aided nucleic acid sequencing |
| JPH09262099A (en) * | 1996-03-28 | 1997-10-07 | Aisin Seiki Co Ltd | Method for detecting nucleic acid etc. by fluorescein derivative phosphate ester |
| US6413718B1 (en) | 1996-05-01 | 2002-07-02 | Visible Genetics Inc. | Method for sequencing of nucleic acid polymers |
| US6124092A (en) * | 1996-10-04 | 2000-09-26 | The Perkin-Elmer Corporation | Multiplex polynucleotide capture methods and compositions |
| EP1009802B1 (en) | 1997-02-12 | 2004-08-11 | Eugene Y. Chan | Methods for analyzimg polymers |
| FR2773218B1 (en) * | 1997-12-31 | 2000-03-10 | Stago International | DEVICE, METHOD AND APPARATUS FOR IMPLEMENTING THE PROCESS, FOR DETERMINING AT LEAST ONE PARTICULAR COMPONENT IN A SAMPLE OF A PRODUCT |
| US6087102A (en) | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
| DE19818999A1 (en) * | 1998-04-28 | 2000-01-20 | Biotechnolog Forschung Gmbh | Device for creating freely definable repertoires |
| US6818437B1 (en) | 1998-05-16 | 2004-11-16 | Applera Corporation | Instrument for monitoring polymerase chain reaction of DNA |
| US7498164B2 (en) | 1998-05-16 | 2009-03-03 | Applied Biosystems, Llc | Instrument for monitoring nucleic acid sequence amplification reaction |
| ATE425448T1 (en) | 1998-05-16 | 2009-03-15 | Applera Corp | OPTICAL DEVICE PARTICULARLY FOR MONITORING DNA POLYMERASE CHAIN REACTIONS |
| US6245507B1 (en) | 1998-08-18 | 2001-06-12 | Orchid Biosciences, Inc. | In-line complete hyperspectral fluorescent imaging of nucleic acid molecules |
| EP1148947B1 (en) * | 1999-01-08 | 2006-10-25 | Applera Corporation | Fibre array for contacting chemical species and methods for using and making same |
| US7056661B2 (en) | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
| US6982146B1 (en) * | 1999-08-30 | 2006-01-03 | The United States Of America As Represented By The Department Of Health And Human Services | High speed parallel molecular nucleic acid sequencing |
| US6535624B1 (en) * | 1999-09-01 | 2003-03-18 | Large Scale Proteomics Corporation | Gel electrophoresis image combining for improved dynamic range |
| US6741983B1 (en) | 1999-09-28 | 2004-05-25 | John D. Birdwell | Method of indexed storage and retrieval of multidimensional information |
| DE10027040A1 (en) * | 2000-06-02 | 2001-12-06 | Basf Lynx Bioscience Ag | Method of making DNA arrays |
| US6397150B1 (en) | 2000-07-27 | 2002-05-28 | Visible Genetics Inc. | Method and apparatus for sequencing of DNA using an internal calibrant |
| US7211414B2 (en) | 2000-12-01 | 2007-05-01 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
| US6653082B2 (en) | 2001-05-17 | 2003-11-25 | Baylor College Of Medicine | Substrate-bound cleavage assay for nucleic acid analysis |
| US20050009022A1 (en) * | 2001-07-06 | 2005-01-13 | Weiner Michael P. | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| US7668697B2 (en) | 2006-02-06 | 2010-02-23 | Andrei Volkov | Method for analyzing dynamic detectable events at the single molecule level |
| EP1412724B1 (en) * | 2001-07-25 | 2016-03-23 | Life Technologies Corporation | Time-delay integration in electrophoretic detection systems |
| US7265833B2 (en) * | 2001-07-25 | 2007-09-04 | Applera Corporation | Electrophoretic system with multi-notch filter and laser excitation source |
| US7222059B2 (en) | 2001-11-15 | 2007-05-22 | Siemens Medical Solutions Diagnostics | Electrophoretic trace simulator |
| FR2833082B1 (en) * | 2001-12-03 | 2004-08-27 | Centre Nat Rech Scient | POSITIONING DETECTION AND DETERMINATION OF SEPARATE BIOLOGICAL MOLECULES ON A SURFACE, USING THE MEASUREMENT OF AN ELECTRICAL PROPERTY OR EFFECT |
| JP3875090B2 (en) * | 2001-12-12 | 2007-01-31 | 独立行政法人科学技術振興機構 | Method and apparatus for preventing condensation and freezing of optical glass window |
| AU2003206401A1 (en) * | 2002-01-08 | 2003-07-24 | Integrated Nano-Technologies, Llc | Method for detecting nucleic acid molecules based on the relative movement of surfaces |
| JP3818926B2 (en) * | 2002-02-04 | 2006-09-06 | 富士写真フイルム株式会社 | Receptor-ligand association reaction method |
| US20030177380A1 (en) * | 2002-03-18 | 2003-09-18 | Woods Stanley P. | Devices for storing array data and methods of using the same |
| US7162372B2 (en) * | 2002-10-08 | 2007-01-09 | Tse-Wei Wang | Least-square deconvolution (LSD): a method to resolve DNA mixtures |
| EP2290073A3 (en) | 2004-05-28 | 2011-08-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
| US7170050B2 (en) * | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
| US20060062531A1 (en) * | 2004-09-17 | 2006-03-23 | Stephen Turner | Fabrication of optical confinements |
| CA2857878A1 (en) | 2004-11-12 | 2006-12-28 | Asuragen, Inc. | Methods and compositions involving mirna and mirna inhibitor molecules |
| WO2006099421A2 (en) | 2005-03-14 | 2006-09-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
| EP1731620A1 (en) | 2005-06-07 | 2006-12-13 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for the diagnosis of immune graft tolerance |
| US7805081B2 (en) * | 2005-08-11 | 2010-09-28 | Pacific Biosciences Of California, Inc. | Methods and systems for monitoring multiple optical signals from a single source |
| US20070202515A1 (en) * | 2005-10-12 | 2007-08-30 | Pathologica, Llc. | Promac signature application |
| US8133741B2 (en) | 2005-10-26 | 2012-03-13 | General Electric Company | Methods and systems for delivery of fluidic samples to sensor arrays |
| US7723120B2 (en) | 2005-10-26 | 2010-05-25 | General Electric Company | Optical sensor array system and method for parallel processing of chemical and biochemical information |
| US8703734B2 (en) | 2005-12-12 | 2014-04-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nanoprobes for detection or modification of molecules |
| ATE481505T1 (en) * | 2005-12-12 | 2010-10-15 | Us Gov Health & Human Serv | NUCLEIC ACID SEQUENCING PROBE AND METHOD OF USE |
| US7715001B2 (en) | 2006-02-13 | 2010-05-11 | Pacific Biosciences Of California, Inc. | Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources |
| US7995202B2 (en) * | 2006-02-13 | 2011-08-09 | Pacific Biosciences Of California, Inc. | Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources |
| US7692783B2 (en) * | 2006-02-13 | 2010-04-06 | Pacific Biosciences Of California | Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources |
| JP5130634B2 (en) * | 2006-03-08 | 2013-01-30 | ソニー株式会社 | Self-luminous display device, electronic device, burn-in correction device, and program |
| CA2657576C (en) | 2006-07-14 | 2023-10-31 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
| US8207509B2 (en) | 2006-09-01 | 2012-06-26 | Pacific Biosciences Of California, Inc. | Substrates, systems and methods for analyzing materials |
| WO2008028160A2 (en) * | 2006-09-01 | 2008-03-06 | Pacific Biosciences Of California, Inc. | Substrates, systems and methods for analyzing materials |
| JP2010510964A (en) | 2006-09-19 | 2010-04-08 | アシュラジェン インコーポレイテッド | MiR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu-miR-292 as targets for therapeutic intervention Genes and pathways regulated by 3p |
| WO2008036765A2 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
| US20080080059A1 (en) * | 2006-09-28 | 2008-04-03 | Pacific Biosciences Of California, Inc. | Modular optical components and systems incorporating same |
| US7640223B2 (en) * | 2006-11-16 | 2009-12-29 | University Of Tennessee Research Foundation | Method of organizing and presenting data in a table using stutter peak rule |
| US7624087B2 (en) * | 2006-11-16 | 2009-11-24 | University Of Tennessee Research Foundation | Method of expert system analysis of DNA electrophoresis data |
| US7664719B2 (en) * | 2006-11-16 | 2010-02-16 | University Of Tennessee Research Foundation | Interaction method with an expert system that utilizes stutter peak rule |
| EA201201640A1 (en) | 2007-01-30 | 2013-09-30 | Фармасайкликс, Инк. | METHODS FOR DETERMINING CANCER STABILITY TO INHIBITORS HISTONEDEISETHYLASE |
| EP1961825A1 (en) | 2007-02-26 | 2008-08-27 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Method for predicting the occurrence of metastasis in breast cancer patients |
| US7998414B2 (en) * | 2007-02-28 | 2011-08-16 | Corning Incorporated | System for high throughput GPCR functional assay |
| US7883898B2 (en) | 2007-05-07 | 2011-02-08 | General Electric Company | Method and apparatus for measuring pH of low alkalinity solutions |
| US20100167413A1 (en) * | 2007-05-10 | 2010-07-01 | Paul Lundquist | Methods and systems for analyzing fluorescent materials with reduced autofluorescence |
| US20080277595A1 (en) * | 2007-05-10 | 2008-11-13 | Pacific Biosciences Of California, Inc. | Highly multiplexed confocal detection systems and methods of using same |
| US8717426B2 (en) * | 2007-05-17 | 2014-05-06 | M-I Llc | Liquid and solids analysis of drilling fluids using fractionation and imaging |
| US8759077B2 (en) | 2007-08-28 | 2014-06-24 | Lightspeed Genomics, Inc. | Apparatus for selective excitation of microparticles |
| US8222040B2 (en) * | 2007-08-28 | 2012-07-17 | Lightspeed Genomics, Inc. | Nucleic acid sequencing by selective excitation of microparticles |
| US8658379B2 (en) | 2008-01-29 | 2014-02-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | Follistatin-like protein-1 as a biomarker for sepsis |
| WO2009097424A1 (en) * | 2008-01-29 | 2009-08-06 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Fstl-1 as a biomarker of inflammation |
| EP3269824A1 (en) | 2008-03-28 | 2018-01-17 | Pacific Biosciences Of California, Inc. | Compositions and methods for nucleic acid sequencing |
| WO2009129183A1 (en) * | 2008-04-15 | 2009-10-22 | Bio-Rad Laboratories, Inc. | Transfection by laser poration on rotating cylinder |
| US8258111B2 (en) | 2008-05-08 | 2012-09-04 | The Johns Hopkins University | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
| JP5892791B2 (en) | 2008-05-14 | 2016-03-23 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Methods and kits for monitoring the effects of immunomodulators on adaptive immunity |
| US20110201519A1 (en) | 2008-08-18 | 2011-08-18 | Sarwal Minnie M | Methods and Compositions for Determining a Graft Tolerant Phenotype in a Subject |
| DK3629011T3 (en) | 2008-09-16 | 2024-01-29 | Pacific Biosciences California Inc | INTEGRATED OPTICAL DEVICE |
| BR112012003847B1 (en) | 2009-08-22 | 2020-12-01 | The Board Of Trustees Of The Leland Standford Junior University | method for selecting one or more human embryos that are likely to reach the blastocyst stage |
| EP3185013B1 (en) | 2009-12-02 | 2019-10-09 | The Board of Trustees of the Leland Stanford Junior University | Biomarkers for determining an allograft tolerant phenotype |
| GB0922085D0 (en) | 2009-12-17 | 2010-02-03 | Cambridge Entpr Ltd | Cancer diagnosis and treatment |
| US8965076B2 (en) | 2010-01-13 | 2015-02-24 | Illumina, Inc. | Data processing system and methods |
| US8994946B2 (en) | 2010-02-19 | 2015-03-31 | Pacific Biosciences Of California, Inc. | Integrated analytical system and method |
| EP3460458B1 (en) | 2010-02-19 | 2021-08-11 | Pacific Biosciences of California, Inc. | A method for nucleic acid sequencing |
| EP3214174B1 (en) | 2010-03-04 | 2019-10-16 | InteRNA Technologies B.V. | A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt |
| US8502867B2 (en) | 2010-03-19 | 2013-08-06 | Lightspeed Genomics, Inc. | Synthetic aperture optics imaging method using minimum selective excitation patterns |
| US9465228B2 (en) | 2010-03-19 | 2016-10-11 | Optical Biosystems, Inc. | Illumination apparatus optimized for synthetic aperture optics imaging using minimum selective excitation patterns |
| WO2011133538A1 (en) | 2010-04-19 | 2011-10-27 | The Procter & Gamble Company | Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto |
| KR101490573B1 (en) | 2010-04-19 | 2015-02-05 | 시네론 메디컬 리미티드 | Combined energy and topical composition application for regulating the condition of mammalian skin |
| WO2011139721A1 (en) | 2010-04-27 | 2011-11-10 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
| WO2011146725A1 (en) | 2010-05-19 | 2011-11-24 | Bayer Healthcare Llc | Biomarkers for a multikinase inhibitor |
| NZ605420A (en) | 2010-07-06 | 2015-02-27 | Interna Technologies Bv | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
| WO2012019099A2 (en) | 2010-08-05 | 2012-02-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Follistatin-like-protein-1 as a biomarker for inflammatory disorders |
| EA201390370A1 (en) | 2010-09-15 | 2013-07-30 | Олмак Дайэгностикс Лимитед | MOLECULAR DIAGNOSTIC TEST FOR DETERMINATION OF ONCOLOGICAL DISEASE |
| CA2817882C (en) | 2010-11-17 | 2022-08-23 | Asuragen, Inc. | Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms |
| EP2474617A1 (en) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | Mir for treating neo-angiogenesis |
| CA2827945C (en) | 2011-02-23 | 2021-10-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of detecting aneuploidy in human embryos |
| MX2013009863A (en) | 2011-02-28 | 2013-12-06 | Univ Iowa Res Found | ANTI-MÜLLERIAN HORMONE CHANGES IN PREGNANCY AND PREDICTION OFADVERSE PREGNANCY OUTCOMES AND GENDER. |
| SG10201604497UA (en) | 2011-06-02 | 2016-07-28 | Almac Diagnostics Ltd | Molecular Diagnostic Test For Cancer |
| WO2013040251A2 (en) | 2011-09-13 | 2013-03-21 | Asurgen, Inc. | Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease |
| US20130157884A1 (en) | 2011-10-26 | 2013-06-20 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
| EP2771487A1 (en) | 2011-10-27 | 2014-09-03 | Asuragen, INC. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
| CA2862580A1 (en) | 2011-10-28 | 2013-05-02 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to nae inhibitors |
| CA2855368A1 (en) | 2011-11-11 | 2013-05-16 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to proteasome inhibitors |
| CA2855356A1 (en) | 2011-11-11 | 2013-05-16 | Millennium Pharmaceuticals, Inc. | Biomarkers of response to proteasome inhibitors |
| WO2013087789A1 (en) | 2011-12-13 | 2013-06-20 | Glykos Finland Ltd. | Antibody isoform arrays and methods thereof |
| CN102703314B (en) * | 2012-05-24 | 2013-09-04 | 中国科学院北京基因组研究所 | Control system for DNA (Deoxyribose Nucleic Acid) sequencer |
| US9372308B1 (en) | 2012-06-17 | 2016-06-21 | Pacific Biosciences Of California, Inc. | Arrays of integrated analytical devices and methods for production |
| US20150152499A1 (en) | 2012-07-03 | 2015-06-04 | Interna Technologies B.V. | Diagnostic portfolio and its uses |
| JP6486826B2 (en) | 2012-10-01 | 2019-03-20 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Biomarkers and methods for predicting response to inhibitors and uses thereof |
| US20140100124A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
| DK2925888T3 (en) | 2012-11-28 | 2017-12-18 | Merck Sharp & Dohme | COMPOSITIONS AND METHODS OF CANCER TREATMENT |
| CA2893033A1 (en) | 2012-12-03 | 2014-06-12 | Almac Diagnostics Limited | Molecular diagnostic test for cancer |
| EP2936222B1 (en) | 2012-12-18 | 2019-07-03 | Pacific Biosciences Of California, Inc. | An optical analytical device |
| EP2959283B1 (en) | 2013-02-22 | 2022-08-17 | Pacific Biosciences of California, Inc. | Integrated illumination of optical analytical devices |
| US9758835B2 (en) | 2013-03-15 | 2017-09-12 | Baylor Research Institute | Ulcerative colitis (UC)-associated colorectal neoplasia markers |
| US9868992B2 (en) | 2013-03-15 | 2018-01-16 | Baylor Research Institute | Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
| US9944992B2 (en) | 2013-03-15 | 2018-04-17 | The University Of Chicago | Methods and compositions related to T-cell activity |
| US20160304969A1 (en) | 2013-12-17 | 2016-10-20 | Merck Sharp & Dohme Corp. | Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonists |
| GB201409479D0 (en) | 2014-05-28 | 2014-07-09 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
| WO2016025510A1 (en) | 2014-08-12 | 2016-02-18 | Rappolee Daniel A | Systems and methods to detect stem cell stress and uses thereof |
| CN107003241B (en) | 2014-08-27 | 2022-01-11 | 加利福尼亚太平洋生物科学股份有限公司 | Integrated analytical device array |
| US11543411B2 (en) | 2014-12-05 | 2023-01-03 | Prelude Corporation | DCIS recurrence and invasive breast cancer |
| EP3230498B1 (en) | 2014-12-09 | 2023-01-18 | Merck Sharp & Dohme LLC | System and methods for deriving gene signature biomarkers of response to pd-1 antagonists |
| US10487356B2 (en) | 2015-03-16 | 2019-11-26 | Pacific Biosciences Of California, Inc. | Integrated devices and systems for free-space optical coupling |
| EP3839510A3 (en) | 2015-04-17 | 2021-08-25 | Merck Sharp & Dohme Corp. | Blood-based biomarkers of tumor sensitivity to pd-1 antagonists |
| US11983790B2 (en) | 2015-05-07 | 2024-05-14 | Pacific Biosciences Of California, Inc. | Multiprocessor pipeline architecture |
| EP4425153A3 (en) | 2015-06-12 | 2024-11-20 | Pacific Biosciences Of California, Inc. | Integrated target waveguide devices and systems for optical coupling |
| GB201512869D0 (en) | 2015-07-21 | 2015-09-02 | Almac Diagnostics Ltd | Gene signature for minute therapies |
| EP3446123A4 (en) | 2016-04-20 | 2019-11-06 | LDX Prognostics Limited Co. | METHODS AND COMPOSITIONS FOR PROGNOSING PREMATURE BIRTH |
| WO2017197573A1 (en) | 2016-05-17 | 2017-11-23 | Ldx Prognostics Limited Co. | Methods and compositions for providing preeclampsia assessment |
| MX2019012741A (en) | 2017-04-28 | 2020-01-21 | Merck Sharp & Dohme | BIOMARKERS FOR THERAPEUTIC AGENTS AGAINST CANCER. |
| EP3704250A1 (en) | 2017-11-03 | 2020-09-09 | InteRNA Technologies B.V. | Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation |
| EP3714053B1 (en) | 2017-11-22 | 2025-12-31 | The University of Chicago | CHEMICAL PROBE-DUE ASSESSMENT OF PROTEIN ACTIVITY AND USE THEREOF |
| WO2019109016A1 (en) | 2017-12-01 | 2019-06-06 | Millennium Pharmaceuticals, Inc. | Biomarkers and methods for treatment with nae inhibitors |
| CN111801937B8 (en) | 2018-01-30 | 2022-10-14 | 瑞巴斯生物系统 | Method and system for detecting particles using structured illumination |
| TWI660218B (en) * | 2018-02-22 | 2019-05-21 | 致茂電子股份有限公司 | Automatic fluorescence detection system |
| US11957695B2 (en) | 2018-04-26 | 2024-04-16 | The Broad Institute, Inc. | Methods and compositions targeting glucocorticoid signaling for modulating immune responses |
| WO2019213660A2 (en) | 2018-05-04 | 2019-11-07 | The Broad Institute, Inc. | Compositions and methods for modulating cgrp signaling to regulate innate lymphoid cell inflammatory responses |
| WO2020036926A1 (en) | 2018-08-17 | 2020-02-20 | Cellecta, Inc. | Multiplex preparation of barcoded gene specific dna fragments |
| WO2020056338A1 (en) | 2018-09-14 | 2020-03-19 | Prelude Corporation | Method of selection for treatment of subjects at risk of invasive breast cancer |
| WO2020077135A1 (en) | 2018-10-10 | 2020-04-16 | Dana-Farber Cancer Institute, Inc. | Modulating resistance to bcl-2 inhibitors |
| US12402610B2 (en) | 2018-11-09 | 2025-09-02 | The Broad Institute, Inc. | Methods and compositions for modulating innate lymphoid cell pathogenic effectors |
| CA3131740A1 (en) | 2019-02-27 | 2020-09-03 | Madera Therapeutics, LLC | Use of caseinolytic protease p function as a biomarker of drug response to imipridone-like agents |
| WO2020186101A1 (en) | 2019-03-12 | 2020-09-17 | The Broad Institute, Inc. | Detection means, compositions and methods for modulating synovial sarcoma cells |
| EP3937969A1 (en) | 2019-03-14 | 2022-01-19 | The Broad Institute, Inc. | Compositions and methods for modulating cgrp signaling to regulate intestinal innate lymphoid cells |
| EP3942023A1 (en) | 2019-03-18 | 2022-01-26 | The Broad Institute, Inc. | Compositions and methods for modulating metabolic regulators of t cell pathogenicity |
| US20220152148A1 (en) | 2019-03-18 | 2022-05-19 | The Broad Institute, Inc. | Modulation of type 2 immunity by targeting clec-2 signaling |
| US20220205035A1 (en) | 2019-04-05 | 2022-06-30 | Board Of Regents, The University Of Texas System | Methods and applications for cell barcoding |
| WO2020210521A2 (en) | 2019-04-12 | 2020-10-15 | The Regents Of The University Of California | Compositions and methods for increasing muscle mass and oxidative metabolism |
| CN110286221A (en) * | 2019-06-11 | 2019-09-27 | 遵义医学院附属医院 | A remote observation system for monitoring HPV hybrid capture |
| WO2021030627A1 (en) | 2019-08-13 | 2021-02-18 | The General Hospital Corporation | Methods for predicting outcomes of checkpoint inhibition and treatment thereof |
| US12421557B2 (en) | 2019-08-16 | 2025-09-23 | The Broad Institute, Inc. | Methods for predicting outcomes and treating colorectal cancer using a cell atlas |
| US12195725B2 (en) | 2019-10-03 | 2025-01-14 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating and detecting tissue specific TH17 cell pathogenicity |
| US11981922B2 (en) | 2019-10-03 | 2024-05-14 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment |
| US11793787B2 (en) | 2019-10-07 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis |
| US11844800B2 (en) | 2019-10-30 | 2023-12-19 | Massachusetts Institute Of Technology | Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia |
| US20230044602A1 (en) | 2019-12-20 | 2023-02-09 | EDWARD Via COLLEGE OF OSTEOPATHIC MEDICINE | Cancer signatures, methods of generating cancer signatures, and uses thereof |
| US12165747B2 (en) | 2020-01-23 | 2024-12-10 | The Broad Institute, Inc. | Molecular spatial mapping of metastatic tumor microenvironment |
| AU2021222009A1 (en) | 2020-02-18 | 2022-09-15 | Pacific Biosciences Of California, Inc. | Highly multiplexed nucleic acid sequencing systems |
| AU2021321586A1 (en) | 2020-08-07 | 2023-03-16 | Dana-Farber Cancer Institute, Inc. | Therapeutic targeting of phosphate dysregulation in cancer via the XPR1:KIDINS220 protein complex |
| WO2022192419A2 (en) | 2021-03-09 | 2022-09-15 | Massachusetts Institute Of Technology | Methods of treating inflammatory bowel disease (ibd) with anti- tnf-blockade |
| US12535417B2 (en) | 2021-05-04 | 2026-01-27 | Pacific Biosciences Of California, Inc. | Arrays of integrated analytical devices with reduced-scale unit cell |
| CN114164100A (en) * | 2021-12-31 | 2022-03-11 | 上海山恒生态科技股份有限公司 | Environmental protection aerobic bacteria cultivates and uses hybridization appearance |
| WO2024028794A1 (en) | 2022-08-02 | 2024-02-08 | Temple Therapeutics BV | Methods for treating endometrial and ovarian hyperproliferative disorders |
| CN115445674B (en) * | 2022-08-24 | 2023-07-14 | 芜湖大捷离合器有限公司 | High-low temperature damp-heat test box |
| WO2024124044A1 (en) | 2022-12-07 | 2024-06-13 | The Brigham And Women’S Hospital, Inc. | Compositions and methods targeting sat1 for enhancing anti¬ tumor immunity during tumor progression |
| WO2024192141A1 (en) | 2023-03-13 | 2024-09-19 | Dana-Farber Cancer Institute, Inc. | Treatment of cancers having a drug-resistant mesenchymal cell state |
| WO2024226838A2 (en) | 2023-04-25 | 2024-10-31 | The Brigham And Women's Hospital, Inc. | Treatment of autoimmune diseases having a pathogenic t cell state |
| WO2025248505A1 (en) | 2024-05-31 | 2025-12-04 | Wayne State University | Methods for treating endometrial and ovarian hyperproliferative disorders |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200313A (en) * | 1983-08-05 | 1993-04-06 | Miles Inc. | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8724023D0 (en) * | 1987-10-13 | 1987-11-18 | Donovan K O | Handling blot processing |
| US5112736A (en) * | 1989-06-14 | 1992-05-12 | University Of Utah | Dna sequencing using fluorescence background electroblotting membrane |
| GB9004596D0 (en) * | 1990-03-01 | 1990-04-25 | Amersham Int Plc | Apparatus for treating analytes |
| AU1999092A (en) * | 1991-05-24 | 1992-12-30 | Walter Gilbert | Method and apparatus for rapid nucleic acid sequencing |
-
1993
- 1993-10-22 US US08/141,234 patent/US5470710A/en not_active Expired - Lifetime
-
1994
- 1994-10-18 WO PCT/US1994/011918 patent/WO1995011961A1/en not_active Ceased
- 1994-10-18 AU AU81222/94A patent/AU8122294A/en not_active Abandoned
- 1994-10-18 EP EP95900382A patent/EP0724627A4/en not_active Withdrawn
- 1994-10-18 CA CA002174779A patent/CA2174779A1/en not_active Abandoned
-
1995
- 1995-11-28 US US08/563,462 patent/US20020012910A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5200313A (en) * | 1983-08-05 | 1993-04-06 | Miles Inc. | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies |
Cited By (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9096898B2 (en) | 1998-05-01 | 2015-08-04 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US9458500B2 (en) | 1998-05-01 | 2016-10-04 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US20050032076A1 (en) * | 1998-05-01 | 2005-02-10 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| US7645596B2 (en) | 1998-05-01 | 2010-01-12 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US20110183321A1 (en) * | 1998-05-01 | 2011-07-28 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| US10214774B2 (en) | 1998-05-01 | 2019-02-26 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US10208341B2 (en) | 1998-05-01 | 2019-02-19 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US9957561B2 (en) | 1998-05-01 | 2018-05-01 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US9725764B2 (en) | 1998-05-01 | 2017-08-08 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US9540689B2 (en) | 1998-05-01 | 2017-01-10 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US9212393B2 (en) | 1998-05-01 | 2015-12-15 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| US20050147992A1 (en) * | 1999-06-28 | 2005-07-07 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
| US20060019263A1 (en) * | 1999-06-28 | 2006-01-26 | Stephen Quake | Methods and apparatuses for analyzing polynucleotide sequences |
| US20050014175A1 (en) * | 1999-06-28 | 2005-01-20 | California Institute Of Technology | Methods and apparatuses for analyzing polynucleotide sequences |
| US7462449B2 (en) | 1999-06-28 | 2008-12-09 | California Institute Of Technology | Methods and apparatuses for analyzing polynucleotide sequences |
| US7045287B2 (en) * | 1999-07-20 | 2006-05-16 | Agilent Technologies, Inc. | Method for contacting fluid components with moieties on a surface |
| US20020001803A1 (en) * | 1999-07-20 | 2002-01-03 | Smith Douglas H. | Method for contacting fluid components with moieties on a surface |
| US7297518B2 (en) | 2001-03-12 | 2007-11-20 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
| US8625094B2 (en) * | 2001-07-25 | 2014-01-07 | Applied Biosystems, Llc | DNA sequencing system |
| US20130011842A1 (en) * | 2001-07-25 | 2013-01-10 | Life Technologies Corporation | DNA Sequencing System |
| US20120196296A1 (en) * | 2001-07-25 | 2012-08-02 | Life Technologies Corporation | DNA Sequencing System |
| US8384899B2 (en) * | 2001-07-25 | 2013-02-26 | Applied Biosystems, Llc | DNA sequencing system |
| US8384898B2 (en) | 2001-07-25 | 2013-02-26 | Applied Biosystems, Llc | DNA sequencing system |
| US6913931B2 (en) | 2002-10-03 | 2005-07-05 | 3M Innovative Properties Company | Devices, methods and systems for low volume microarray processing |
| US20050163664A1 (en) * | 2002-10-03 | 2005-07-28 | 3M Innovative Properties Company | Devices, methods and systems for low volume microarray processing |
| US20050170367A1 (en) * | 2003-06-10 | 2005-08-04 | Quake Stephen R. | Fluorescently labeled nucleoside triphosphates and analogs thereof for sequencing nucleic acids |
| US20060147901A1 (en) * | 2003-07-02 | 2006-07-06 | Greve Jan | Devices and methods to image objects by time delay integration |
| EP1656545A4 (en) * | 2003-08-11 | 2010-06-09 | Immunivest Corp | DEVICES AND METHODS FOR IMAGING OBJECTS BY INTEGRATION IN TIME |
| US9657344B2 (en) | 2003-11-12 | 2017-05-23 | Fluidigm Corporation | Short cycle methods for sequencing polynucleotides |
| US9012144B2 (en) | 2003-11-12 | 2015-04-21 | Fluidigm Corporation | Short cycle methods for sequencing polynucleotides |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US7491498B2 (en) | 2003-11-12 | 2009-02-17 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US7897345B2 (en) | 2003-11-12 | 2011-03-01 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US20060172408A1 (en) * | 2003-12-01 | 2006-08-03 | Quake Steven R | Device for immobilizing chemical and biochemical species and methods of using same |
| US7767439B2 (en) | 2003-12-10 | 2010-08-03 | Samsung Electronics Co., Ltd. | Real-time PCR monitoring apparatus and method |
| US8697433B2 (en) | 2003-12-10 | 2014-04-15 | Samsung Electronics Co., Ltd. | Polymerase chain reaction (PCR) module and multiple PCR system using the same |
| US20050130183A1 (en) * | 2003-12-10 | 2005-06-16 | Oh Kwang-Wook | Real-time PCR monitoring apparatus and method |
| US20050164281A1 (en) * | 2003-12-10 | 2005-07-28 | Oh Kwang-Wook | Polymerase chain reaction (PCR) module and multiple PCR system using the same |
| US7799557B2 (en) | 2003-12-10 | 2010-09-21 | Samsung Electronics Co., Ltd. | Polymerase chain reaction (PCR) module and multiple PCR system using the same |
| US20100311070A1 (en) * | 2003-12-10 | 2010-12-09 | Samsung Electronics Co., Ltd. | Polymerase chain reaction (pcr) module and multiple pcr system using the same |
| EP1541237A3 (en) * | 2003-12-10 | 2006-02-01 | Samsung Electronics Co., Ltd. | Polymerase chain reaction (pcr) module and multiple pcr system using the same |
| US7981604B2 (en) | 2004-02-19 | 2011-07-19 | California Institute Of Technology | Methods and kits for analyzing polynucleotide sequences |
| US20060046258A1 (en) * | 2004-02-27 | 2006-03-02 | Lapidus Stanley N | Applications of single molecule sequencing |
| US20050239085A1 (en) * | 2004-04-23 | 2005-10-27 | Buzby Philip R | Methods for nucleic acid sequence determination |
| US7635562B2 (en) | 2004-05-25 | 2009-12-22 | Helicos Biosciences Corporation | Methods and devices for nucleic acid sequence determination |
| US20060019276A1 (en) * | 2004-05-25 | 2006-01-26 | Timothy Harris | Methods and devices for nucleic acid sequence determination |
| US20060024678A1 (en) * | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
| US20060118754A1 (en) * | 2004-12-08 | 2006-06-08 | Lapen Daniel C | Stabilizing a polyelectrolyte multilayer |
| US7220549B2 (en) | 2004-12-30 | 2007-05-22 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
| US20060252077A1 (en) * | 2004-12-30 | 2006-11-09 | Helicos Biosciences Corporation | Stabilizing a nucleic acid for nucleic acid sequencing |
| US20060172328A1 (en) * | 2005-01-05 | 2006-08-03 | Buzby Philip R | Methods and compositions for correcting misincorporation in a nucleic acid synthesis reaction |
| US20060172313A1 (en) * | 2005-01-28 | 2006-08-03 | Buzby Philip R | Methods and compositions for improving fidelity in a nucleic acid synthesis reaction |
| US7482120B2 (en) | 2005-01-28 | 2009-01-27 | Helicos Biosciences Corporation | Methods and compositions for improving fidelity in a nucleic acid synthesis reaction |
| US7971371B2 (en) * | 2005-04-28 | 2011-07-05 | Mabe Canada Inc. | Apparatus and method for controlling a clothes dryer |
| US20080052951A1 (en) * | 2005-04-28 | 2008-03-06 | Mabe Canada Inc. | Apparatus and method for controlling a clothes dryer |
| US20060263790A1 (en) * | 2005-05-20 | 2006-11-23 | Timothy Harris | Methods for improving fidelity in a nucleic acid synthesis reaction |
| US9868978B2 (en) | 2005-08-26 | 2018-01-16 | Fluidigm Corporation | Single molecule sequencing of captured nucleic acids |
| US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
| US20070117103A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
| US20070117104A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
| US20070117102A1 (en) * | 2005-11-22 | 2007-05-24 | Buzby Philip R | Nucleotide analogs |
| US20070128610A1 (en) * | 2005-12-02 | 2007-06-07 | Buzby Philip R | Sample preparation method and apparatus for nucleic acid sequencing |
| US20070128614A1 (en) * | 2005-12-06 | 2007-06-07 | Liu David R | Nucleotide analogs |
| US7476734B2 (en) | 2005-12-06 | 2009-01-13 | Helicos Biosciences Corporation | Nucleotide analogs |
| US8132676B2 (en) | 2008-08-18 | 2012-03-13 | Emd Millipore Corporation | Hydrophilic, high protein binding, low fluorescence, western blotting membrane |
| US20110045493A1 (en) * | 2008-08-18 | 2011-02-24 | Millipore Corporation | Hydrophilic, High Protein Binding, Low Fluorescence, Western Blotting Membrane |
| US8143067B2 (en) | 2008-08-18 | 2012-03-27 | Emd Millipore Corporation | Hydrophilic, high protein binding, low fluorescence, western blotting membrane |
| CN108700520A (en) * | 2016-02-26 | 2018-10-23 | 辛格科技公司 | Method and apparatus for high-throughput imaging |
| EP3420338B1 (en) * | 2016-02-26 | 2023-05-03 | Single Technologies AB | Method and apparatus for high throughput imaging |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2174779A1 (en) | 1995-05-04 |
| US5470710A (en) | 1995-11-28 |
| EP0724627A4 (en) | 1999-03-31 |
| AU8122294A (en) | 1995-05-22 |
| EP0724627A1 (en) | 1996-08-07 |
| WO1995011961A1 (en) | 1995-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5470710A (en) | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing | |
| EP0823052B1 (en) | A multicapillary fluorescent detection system | |
| US11966086B2 (en) | Determining temperature-varying signal emissions during automated, random-access thermal cycling processes | |
| US10724084B2 (en) | Systems and methods for fluorescence detection with a movable detection module | |
| US7466908B1 (en) | System for rapid nucleic acid amplification and detection | |
| EP1385006A2 (en) | System and cartridge for processing a biological sample | |
| US10393659B2 (en) | Instrument and method for detecting analytes | |
| WO2001090748A2 (en) | High-throughput methods of distinguishing at least one molecule individually in a sample comprising multiple molecules and systems for use therein | |
| US6255048B1 (en) | Highly sensitive fluoroassay | |
| Cherry et al. | Enzyme-linked fluorescent detection for automated multiplex DNA sequencing | |
| Ma et al. | Single‐molecule immunoassay and DNA diagnosis | |
| JP3834519B2 (en) | Biochemical inspection method | |
| Weiss et al. | Automated hybridization/imaging device for fluorescent multiplex DNA sequencing | |
| JP2007534936A (en) | A device to analyze the interaction between target and probe molecules | |
| Karger et al. | Line scanning system for direct digital chemiluminescence imaging of DNA sequencing blots | |
| Yeung | High‐throughput single molecule screening of DNA and proteins | |
| JP2003227813A (en) | Capillary electrophoresis device | |
| AU2003283064B2 (en) | Centrifugal device and method for performing binding assays | |
| JPH1019803A (en) | Base sequence determination method | |
| JPH0698799A (en) | Method for detecting polynucleotide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
